— Know what they know.
Not Investment Advice

UNCY NASDAQ

Unicycive Therapeutics, Inc.
1W: -5.0% 1M: -22.2% 3M: -23.8% YTD: -37.8% 1Y: -29.6% 3Y: -58.5% 5Y: -85.8%
$3.61
+0.03 (+0.84%)
After Hours: $3.58 (-0.02, -0.69%)
Weekly Expected Move ±8.7%
$3 $4 $4 $4 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 26 · $98.9M mcap · 27M float · 5.07% daily turnover · Short 49% of daily vol
Credit Risk of going bust: lower than 61% of companies Debt: 0.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down 99.9%), Unicycive Therapeutics, Inc. would be worth roughly what it owes.
Total debt $671K against a stock market value of $98.1M.
Distance to default 6.37 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $336K (short-term plus half of long-term), stock volatility 84.6%; Altman Z'' -1.95. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
#488 of 1060
Biotechnology
Healthcare · Micro Cap · 778 peers
Market Share
0.0%
Top 4 Concentration: 22.6%

Technical Signal Map

130 Bullish
45 Neutral
604 Bearish
UNCY $110M
Unicycive Therapeutics, Inc.
BEARISH -91
SEPN $1.9B
Septerna Inc
BULLISH +100
COAG $1.6B
Hemab Therapeutics Holdings, Inc. Common Stock
BULLISH +100
VSTM $910M
Verastem, Inc.
BULLISH +100
SOLTF $770M
Nxera Pharma Co., Ltd.
BULLISH +100
PYPD $110M
PolyPid Ltd.
BULLISH +100
ANIX $100M
Anixa Biosciences, Inc.
BULLISH +100
GRDX $40M
GridAI Technologies Corp.
BULLISH +100
KLRA $1.7B
Kailera Therapeutics, Inc.
BULLISH +91
SPTX $1.1B
Seaport Therapeutics, Inc. Common Stock
BULLISH +91
SGP $950M
SpyGlass Pharma, Inc. Common Stock
BULLISH +91
ENTX $510M
Entera Bio Ltd.
BULLISH +91
ATNM $50M
Actinium Pharmaceuticals, Inc.
BULLISH +91
PRME $670M
Prime Medicine, Inc.
BULLISH +87
XFOR $320M
X4 Pharmaceuticals, Inc.
BULLISH +87
CING $70M
Cingulate Inc.
BULLISH +87
ESLA $40M
Estrella Immunopharma, Inc.
BULLISH +87
INDP $360M
Indaptus Therapeutics, Inc.
BULLISH +84
KRRO $180M
Korro Bio, Inc.
BULLISH +84
VIR $1.8B
Vir Biotechnology, Inc.
BULLISH +82
MAZE $1.7B
Maze Therapeutics, Inc.
BULLISH +78
ZIVO $20M
ZIVO Bioscience, Inc.
BULLISH +78
LBRX $1.2B
LB Pharmaceuticals Inc Common Stock
BULLISH +75
OABIW $1.1B
OmniAb, Inc.
BULLISH +75
RIGL $900M
Rigel Pharmaceuticals, Inc.
BULLISH +75
MXCT $140M
MaxCyte, Inc.
BULLISH +75
HURA $140M
TuHURA Biosciences, Inc.
BULLISH +75
IRLA $30M
IRulya Therapeutics Inc.
BULLISH +74
LYEL $230M
Lyell Immunopharma, Inc.
BULLISH +73
AGTX —
Agentix Corp.
BULLISH +73
NAUT $410M
Nautilus Biotechnolgy, Inc.
BULLISH +69
RARE $1.5B
Ultragenyx Pharmaceutical Inc.
BULLISH +68
XNCR $1.9B
Xencor, Inc.
BULLISH +66
TRAX $1.6B
First Tracks Biotherapeutics Inc
BULLISH +66
SLN $930M
Silence Therapeutics plc
BULLISH +66
PBYI $570M
Puma Biotechnology, Inc.
BULLISH +66
SGMT $310M
Sagimet Biosciences Inc.
BULLISH +66
HOWL $50M
Werewolf Therapeutics, Inc.
BULLISH +66
NNVC $40M
NanoViricides, Inc.
BULLISH +66
MBRX $10M
Moleculin Biotech, Inc.
BULLISH +66
AZTR —
Azitra, Inc.
BULLISH +66
NBTX $1.5B
Nanobiotix S.A.
BULLISH +62
BOLT $10M
Bolt Biotherapeutics, Inc.
BULLISH +62
BDRX —
Biodexa Pharmaceuticals Plc
BULLISH +62
CBDG —
THC Farmaceuticals, Inc.
BULLISH +60
NTLA $1.6B
Intellia Therapeutics, Inc.
BULLISH +59
PHAR $710M
Pharming Group N.V.
BULLISH +59
PCSA $10M
Processa Pharmaceuticals, Inc.
BULLISH +59
ICCC $90M
ImmuCell Corporation
BULLISH +58
PLUR $10M
Pluri Inc.
BULLISH +53
CASBF $1.4B
CanSino Biologics Inc.
BULLISH +52
REPL $1.1B
Replimune Group, Inc.
BULLISH +52
PPCB —
Propanc Biopharma, Inc.
BULLISH +52
HALB —
Halberd Corporation
BULLISH +51
ABSI $1.6B
Absci Corporation
BULLISH +50
CRMD $610M
CorMedix Inc.
BULLISH +50
DTIL $180M
Precision BioSciences, Inc.
BULLISH +50
NRXS $90M
NeurAxis, Inc.
BULLISH +50
OKYO $70M
OKYO Pharma Limited
BULLISH +50
XERS $1.9B
Xeris Biopharma Holdings, Inc.
BULLISH +49
ADCT $180M
ADC Therapeutics S.A.
BULLISH +49
SCNLF $170M
Scancell Holdings plc
BULLISH +49
ZEOX $10M
Zeo ScientifiX, Inc.
BULLISH +48
CLGN —
CollPlant Biotechnologies Ltd.
BULLISH +44
VOR $990M
Vor Biopharma Inc.
BULLISH +43
ALEC $200M
Alector, Inc.
BULLISH +43
ACUT —
Accustem Sciences Inc.
BULLISH +43
KNBIF —
Kane Biotech Inc.
BULLISH +43
RXRX $2.0B
Recursion Pharmaceuticals, Inc.
BULLISH +42
KROS $220M
Keros Therapeutics, Inc.
BULLISH +42
TXTM $90M
ProText Mobility, Inc.
BULLISH +42
IMCR $1.6B
Immunocore Holdings plc
BULLISH +41
DMAC $470M
DiaMedica Therapeutics Inc.
BULLISH +41
DMRA $1.3B
Damora Therapeutics, Inc.
BULLISH +40
MLTX $1.0B
MoonLake Immunotherapeutics
BULLISH +40
PDSB $60M
PDS Biotechnology Corporation
BULLISH +38
NYMXF $10M
Nymox Pharmaceutical Corporation
BULLISH +38
IPIX —
Innovation Pharmaceuticals Inc.
BULLISH +38
PULM $10M
Pulmatrix, Inc.
BULLISH +36
TCRT $10M
Alaunos Therapeutics, Inc.
BULLISH +35
EDIT $370M
Editas Medicine, Inc.
BULLISH +34
PEPG $170M
PepGen Inc.
BULLISH +33
NGNE $370M
Neurogene Inc.
LEAN BULL +27
LCTX $250M
Lineage Cell Therapeutics, Inc.
LEAN BULL +27
BCYC $250M
Bicycle Therapeutics plc
LEAN BULL +27
ABOS $140M
Acumen Pharmaceuticals, Inc.
LEAN BULL +27
IUGNF $30M
Imugene Limited
LEAN BULL +27
INFIQ —
Infinity Pharmaceuticals, Inc.
LEAN BULL +27
ARDS —
Aridis Pharmaceuticals, Inc.
LEAN BULL +27
BSSP —
Baseline Productions, Inc.
LEAN BULL +27
PTCHF $390M
PureTech Health plc
LEAN BULL +26
OBIO $340M
Orchestra BioMed Holdings, Inc.
LEAN BULL +26
ACOG $130M
Alpha Cognition Inc
LEAN BULL +26
CKDXF $10M
Ceryvyn Therapeutics Ltd
LEAN BULL +26
PRVCF $10M
PreveCeutical Medical Inc.
LEAN BULL +26
CYYNF —
Cynata Therapeutics Limited
LEAN BULL +26
EFTR —
eFFECTOR Therapeutics, Inc.
LEAN BULL +26
CALA —
Calithera Biosciences, Inc.
LEAN BULL +26
ENSC $10M
Ensysce Biosciences, Inc.
LEAN BULL +25
NTRR —
Neutra Corp.
LEAN BULL +20
STOK $1.6B
Stoke Therapeutics, Inc.
LEAN BULL +18
CCCC $380M
C4 Therapeutics, Inc.
LEAN BULL +18
ZURA $320M
Zura Bio Limited
LEAN BULL +18
BIVI $10M
BioVie Inc.
LEAN BULL +18
VSBC $10M
VitaSpring Biomedical Co. Ltd.
LEAN BULL +18
LOBEF $10M
Lobe Sciences Ltd.
LEAN BULL +18
PXMD —
PaxMedica, Inc. Common Stock
LEAN BULL +18
HEPA —
Hepion Pharmaceuticals, Inc.
LEAN BULL +18
BTAX —
Biostax Corp.
LEAN BULL +18
VAXX —
Vaxxinity, Inc.
LEAN BULL +18
REVB —
Revelation Biosciences, Inc.
LEAN BULL +18
ACHFF $40M
Arch Biopartners Inc.
LEAN BULL +17
PRLD $210M
Prelude Therapeutics Incorporated
LEAN BULL +16
BRVE $1.5B
Braveheart Bio, Inc.
LEAN BULL +15
SRZN $190M
Surrozen, Inc.
LEAN BULL +15
MDNAF $20M
Medicenna Therapeutics Corp.
LEAN BULL +15
ABPO —
Abpro Holdings, Inc.
LEAN BULL +15
CYDY $380M
CytoDyn Inc.
LEAN BULL +13
SPRB $130M
Spruce Biosciences, Inc.
LEAN BULL +13
OCEA —
Ocean Biomedical, Inc.
LEAN BULL +13
PVLA $1.8B
Palvella Therapeutics, Inc.
LEAN BULL +11
TYRA $1.2B
Tyra Biosciences, Inc.
LEAN BULL +11
PRTA $420M
Prothena Corporation plc
LEAN BULL +11
ENTA $340M
Enanta Pharmaceuticals, Inc.
LEAN BULL +11
GLSI $240M
Greenwich LifeSciences, Inc.
LEAN BULL +11
CLNN $60M
Clene Inc.
LEAN BULL +11
EHOS —
Ehouse Global, Inc.
LEAN BULL +11
CPMV —
Mosaic ImmunoEngineering Inc.
LEAN BULL +10
DNAG —
DNAPrint Genomics, Inc.
LEAN BULL +10
ONCSQ —
OncoSec Medical Incorporated
LEAN BULL +10
RBSH —
Rebus Holdings, Inc.
LEAN BULL +10
SRPT $1.9B
Sarepta Therapeutics, Inc.
NEUTRAL +9
ABVC $30M
ABVC BioPharma, Inc.
NEUTRAL +9
ANAB $1.5B
AnaptysBio, Inc.
NEUTRAL +8
STAB —
Statera Biopharma, Inc.
NEUTRAL +8
OBX $10M
Obsidian Therapeutics Inc.
NEUTRAL +6
GBIM —
GlobeImmune, Inc.
NEUTRAL +4
CNSP $10M
CNS Pharmaceuticals, Inc.
NEUTRAL +3
SABS $260M
SAB Biotherapeutics, Inc.
NEUTRAL +2
NWBO $260M
Northwest Biotherapeutics, Inc.
NEUTRAL +2
MLLCF $150M
Molecular Partners AG
NEUTRAL +2
HESG —
Health Sciences Group, Inc.
NEUTRAL +2
CTXR $10M
Citius Pharmaceuticals, Inc.
NEUTRAL +1
RGIN —
Regenicin, Inc.
NEUTRAL +1
RCAR —
RenovaCare, Inc.
NEUTRAL +1
NMTRQ —
9 Meters Biopharma, Inc.
NEUTRAL +1
CFRXQ —
ContraFect Corp.
NEUTRAL +1
LYCA $1.6B
Lycia Therapeutics Inc.
N/A 0
CTY $200M
City Therapeutics Inc.
N/A 0
IAM $130M
Iambic Therapeutics Inc.
N/A 0
ATOS $30M
Atossa Therapeutics, Inc.
NEUTRAL 0
LONA $20M
LeonaBio, Inc.
NEUTRAL 0
ORGS —
Orgenesis Inc.
NEUTRAL 0
JANX $1.0B
Janux Therapeutics, Inc.
NEUTRAL -1
ODTX $940M
Odyssey Therapeutics, Inc.
NEUTRAL -2
DRUG $520M
Bright Minds Biosciences Inc.
NEUTRAL -2
PHMMF $1.6B
Pharma Mar, S.A.
NEUTRAL -3
NMAD $50M
NOMAD Power Solutions, Inc.
NEUTRAL -4
KLDO —
Kaleido Biosciences, Inc.
NEUTRAL -5
CNBX —
CNBX Pharmaceuticals Inc.
NEUTRAL -5
CALC —
CalciMedica, Inc.
NEUTRAL -5
YARW $180M
Yarrow Bioscience Inc
NEUTRAL -6
ELUT $40M
Elutia Inc
NEUTRAL -6
GSTC —
GlobeStar Therapeutics Corporation
NEUTRAL -6
YDESW —
YD Bio Limited Warrants
NEUTRAL -6
BPTH —
Bio-Path Holdings, Inc.
NEUTRAL -6
RNXT $60M
RenovoRx, Inc.
NEUTRAL -7
USRM —
U.S. Stem Cell, Inc.
NEUTRAL -7
ZBIO $1.8B
Zenas BioPharma, Inc.
NEUTRAL -8
VCRE $260M
Vicore Pharma Holding AB
NEUTRAL -8
ENGNW $10M
enGene Holdings Inc. Warrants
NEUTRAL -8
PBLA —
Panbela Therapeutics, Inc.
NEUTRAL -8
EVAX $20M
Evaxion Biotech A/S
NEUTRAL -9
NXTC $20M
NextCure, Inc.
NEUTRAL -9
ATXI —
Avenue Therapeutics, Inc.
NEUTRAL -9
MRPI —
Mera Pharmaceuticals, Inc.
NEUTRAL -9
MBXBF $30M
Microbix Biosystems Inc.
LEAN BEAR -10
INRLF $640M
Valneva SE
LEAN BEAR -12
POLBF $70M
Poolbeg Pharma PLC
LEAN BEAR -12
CLYYF $10M
Celyad Oncology S.A.
LEAN BEAR -12
QPTFF $10M
Quest PharmaTech Inc.
LEAN BEAR -12
OKUR $100M
OnKure Therapeutics, Inc.
LEAN BEAR -14
SNGX $10M
Soligenix, Inc.
LEAN BEAR -14
ENDV —
Endonovo Therapeutics, Inc.
LEAN BEAR -14
APLMW $170M
Apollomics, Inc.
LEAN BEAR -15
ARMP $140M
Armata Pharmaceuticals, Inc.
LEAN BEAR -15
EQ $80M
Equillium, Inc.
LEAN BEAR -15
LEXX $10M
Lexaria Bioscience Corp.
LEAN BEAR -15
KPTI $10M
Karyopharm Therapeutics Inc.
LEAN BEAR -15
ADXN —
Addex Therapeutics Ltd
LEAN BEAR -15
SRBCF —
Sirona Biochem Corp.
LEAN BEAR -16
NKGN —
NKGen Biotech, Inc.
LEAN BEAR -16
REPCF —
RepliCel Life Sciences Inc.
LEAN BEAR -16
IMVIF —
IMV Inc.
LEAN BEAR -16
JUNS —
Jupiter Neurosciences, Inc.
LEAN BEAR -16
MCET —
MultiCell Technologies, Inc.
LEAN BEAR -16
SLGL $230M
Sol-Gel Technologies Ltd.
LEAN BEAR -17
MMIRF $30M
MedMira Inc.
LEAN BEAR -17
JBIO $930M
Jade Biosciences, Inc.
LEAN BEAR -18
CGEM $880M
Cullinan Therapeutics, Inc.
LEAN BEAR -18
ACRS $550M
Aclaris Therapeutics, Inc.
LEAN BEAR -18
IFRX $230M
InflaRx N.V.
LEAN BEAR -18
LADX —
LadRx Corporation
LEAN BEAR -18
LYRA —
Lyra Therapeutics, Inc.
LEAN BEAR -18
PARD —
Poniard Pharmaceuticals, Inc.
LEAN BEAR -18
ADRX $1.9B
ADARx Pharmaceuticals, Inc.
LEAN BEAR -20
AOBI —
American Oriental Bioengineering, Inc.
LEAN BEAR -20
HSTC $210M
HST Global, Inc.
LEAN BEAR -21
DBVT $230M
DBV Technologies S.A.
LEAN BEAR -22
RNA $140M
Atrium Therapeutics, Inc.
LEAN BEAR -22
PBIGF $10M
Paradigm Biopharmaceuticals Limited
LEAN BEAR -22
ADAPY $10M
Adaptimmune Therapeutics plc
LEAN BEAR -22
FPMI —
FluoroPharma Medical, Inc.
LEAN BEAR -22
PREDQ —
Predictive Discovery Limited
LEAN BEAR -22
GBLX —
GB Sciences, Inc.
LEAN BEAR -22
IMMB —
Immunotech Laboratories, Inc.
LEAN BEAR -22
FENC $350M
Fennec Pharmaceuticals Inc.
LEAN BEAR -23
INBX $1.4B
Inhibrx Biosciences Inc.
LEAN BEAR -24
KARD $1.1B
Kardigan, Inc.
LEAN BEAR -24
YDES $350M
YD Bio Limited Ordinary Shares
LEAN BEAR -24
FATE $250M
Fate Therapeutics, Inc.
LEAN BEAR -24
BDTX $110M
Black Diamond Therapeutics, Inc.
LEAN BEAR -24
NTHI $90M
Neonc Technologies Holdings, Inc.
LEAN BEAR -24
SGMOQ $50M
Sangamo Therapeutics, Inc.
LEAN BEAR -24
ENVB $10M
Enveric Biosciences, Inc.
LEAN BEAR -24
PZRXQ —
PhaseRx, Inc.
LEAN BEAR -24
NNLX —
NanoLogix, Inc.
LEAN BEAR -24
CLAZF —
Claritas Pharmaceuticals, Inc.
LEAN BEAR -24
NNBP —
Nanobac Pharmaceuticals, Incorporated
LEAN BEAR -24
GWIN $360M
Glorywin Entertainment Group, Inc.
LEAN BEAR -25
FGHQF $360M
Frontage Holdings Corporation
LEAN BEAR -25
KNTPF $120M
Kintor Pharmaceutical Limited
LEAN BEAR -25
LVCLF $20M
Algorae Pharmaceuticals Limited
LEAN BEAR -25
BCLI $10M
Brainstorm Cell Therapeutics Inc.
LEAN BEAR -25
FORU —
ForU Holdings, Inc.
LEAN BEAR -25
CHNXF —
ChitogenX Inc.
LEAN BEAR -25
HLSQ —
Tessera Defense and Homeland Security Inc
LEAN BEAR -25
CMND —
Clearmind Medicine Inc.
LEAN BEAR -25
VINC —
Vincerx Pharma, Inc.
LEAN BEAR -25
NURPF $1.8B
Neuren Pharmaceuticals Limited
LEAN BEAR -26
CUBT —
Curative Biotechnology, Inc.
LEAN BEAR -26
KZIA $10M
Kazia Therapeutics Ltd ADR
LEAN BEAR -27
LIANY —
LianMedical
LEAN BEAR -28
TSHA $1.3B
Taysha Gene Therapies, Inc.
BEARISH -31
ARVN $470M
Arvinas, Inc.
BEARISH -31
CAMP $210M
CAMP4 Therapeutics Corporation
BEARISH -31
PBMWW —
Psyence Biomedical Ltd. Warrant
BEARISH -31
CARM —
Carisma Therapeutics, Inc.
BEARISH -31
TRVN —
Trevena, Inc.
BEARISH -31
PKTX —
ProtoKinetix, Incorporated
BEARISH -31
INNMF $30M
Amplia Therapeutics Limited
BEARISH -32
IMUC $10M
EOM Pharmaceuticals Holdings, Inc.
BEARISH -32
AAGH —
America Great Health
BEARISH -32
BXRXQ —
Baudax Bio, Inc.
BEARISH -32
SNBIF $1.3B
SanBio Company Limited
BEARISH -33
OVID $420M
Ovid Therapeutics Inc.
BEARISH -33
RZLT $370M
Rezolute, Inc.
BEARISH -33
MDWD $150M
MediWound Ltd.
BEARISH -33
CSBR $70M
Champions Oncology, Inc.
BEARISH -33
MRKR $20M
Marker Therapeutics, Inc.
BEARISH -33
DTCFF $20M
Defence Therapeutics Inc.
BEARISH -33
XCUR $10M
Exicure, Inc.
BEARISH -33
VRCI —
Verde Science, Inc.
BEARISH -33
HLUN —
HEALTHeUNIVERSE, Inc.
BEARISH -33
SNNAQ —
Sienna Biopharmaceuticals, Inc.
BEARISH -33
IBOGF —
Universal Ibogaine Inc.
BEARISH -33
NTII —
Neurobiological Technologies, Inc.
BEARISH -33
GLSHQ —
Gelesis Holdings, Inc.
BEARISH -33
CMRA —
Comera Life Sciences Holdings, Inc.
BEARISH -33
HAVLF —
HAVN Life Sciences Inc.
BEARISH -33
PSYBF —
PsyBio Therapeutics Corp
BEARISH -33
TLOG —
TetraLogic Pharmaceuticals Corporation
BEARISH -33
MRZM —
Marizyme, Inc.
BEARISH -33
TRVI $1.8B
Trevi Therapeutics, Inc.
BEARISH -34
QURE $1.6B
uniQure N.V.
BEARISH -34
BPMUF $960M
Basilea Pharmaceutica AG
BEARISH -34
DNA $670M
Ginkgo Bioworks Holdings, Inc.
BEARISH -34
INKT $50M
MiNK Therapeutics, Inc.
BEARISH -34
CURX $10M
Curanex Pharmaceuticals Inc Common Stock
BEARISH -34
SYGGF —
Synairgen plc
BEARISH -34
RAPP $1.2B
Rapport Therapeutics, Inc. Common Stock
BEARISH -35
ATGGF $140M
Actinogen Medical Limited
BEARISH -35
NRXP $110M
NRx Pharmaceuticals, Inc.
BEARISH -35
SQZB —
SQZ Biotechnologies Company
BEARISH -35
MEOBF $2.0B
Mesoblast Limited
BEARISH -37
CEROW —
CERo Therapeutics Holdings, Inc.
BEARISH -39
BCRX $1.9B
BioCryst Pharmaceuticals, Inc.
BEARISH -40
APMD $790M
Apnimed, Inc.
BEARISH -40
STTK $550M
Shattuck Labs, Inc.
BEARISH -40
BNTC $300M
Benitec Biopharma Inc.
BEARISH -40
ELDN $190M
Eledon Pharmaceuticals, Inc.
BEARISH -40
CHRS $160M
Coherus Oncology, Inc.
BEARISH -40
FHTX $120M
Foghorn Therapeutics Inc.
BEARISH -40
MAIA $70M
MAIA Biotechnology, Inc.
BEARISH -40
AURX $60M
Nuo Therapeutics, Inc.
BEARISH -40
RNTX $50M
Rein Therapeutics Inc.
BEARISH -40
ELTX $40M
Elicio Therapeutics, Inc.
BEARISH -40
JSPR $20M
Jasper Therapeutics, Inc.
BEARISH -40
NCNA $10M
NuCana plc
BEARISH -40
GDTC $10M
CytoMed Therapeutics Limited
BEARISH -40
RLFTY —
MindMaze Therapeutics Holding S.A.
BEARISH -40
JAGX —
Jaguar Health, Inc.
BEARISH -40
HTDS —
Hard to Treat Diseases Inc.
BEARISH -40
BIXT —
Bioxytran, Inc.
BEARISH -40
ITMC —
Itoco Inc.
BEARISH -40
PPTDF $870M
PeptiDream Inc.
BEARISH -41
TRDA $170M
Entrada Therapeutics, Inc.
BEARISH -41
ERNA —
Ernexa Therapeutics Inc.
BEARISH -41
MRES —
Institute of Biomedical Research Corp.
BEARISH -41
CSPHF $1.4B
CStone Pharmaceuticals
BEARISH -42
DRTSW $1.2B
Alpha Tau Medical Ltd.
BEARISH -42
RLYB $90M
Rallybio Corporation
BEARISH -42
LSTA $10M
Lisata Therapeutics, Inc.
BEARISH -42
AEON $10M
AEON Biopharma, Inc.
BEARISH -42
PROT —
Proteonomix, Inc.
BEARISH -42
NBIO —
Nascent Biotech, Inc.
BEARISH -42
SIGY —
Sigyn Therapeutics, Inc.
BEARISH -42
ONCO —
Onconetix, Inc.
BEARISH -42
RNUGF —
ReNeuron Group plc
BEARISH -42
BRAXF —
Braxia Scientific Corp.
BEARISH -42
PFND —
Pathfinder Cell Therapy, Inc.
BEARISH -42
CDXI —
Cardax, Inc.
BEARISH -42
ADYX —
Adynxx, Inc.
BEARISH -42
PANC —
Panacos Pharmaceuticals, Inc.
BEARISH -42
SYVC —
Synovics Pharmaceuticals, Inc.
BEARISH -42
WHWK $180M
Whitehawk Therapeutics Inc
BEARISH -43
ATRA $90M
Atara Biotherapeutics, Inc.
BEARISH -43
HNSBF $330M
Hansa Biopharma AB (publ)
BEARISH -44
VICP $10M
Vicapsys Life Sciences, Inc.
BEARISH -44
VOGX $260M
Vogenx Inc.
BEARISH -45
CASIF —
CASI Pharmaceuticals, Inc.
BEARISH -46
IDRSF $1.4B
Idorsia Ltd
BEARISH -47
VBIZF $400M
Viva Biotech Holdings
BEARISH -47
RCKT $250M
Rocket Pharmaceuticals, Inc.
BEARISH -47
CRVS $890M
Corvus Pharmaceuticals, Inc.
BEARISH -48
SVRA $870M
Savara Inc.
BEARISH -48
IMRX $240M
Immuneering Corporation
BEARISH -48
PMN $70M
ProMIS Neurosciences, Inc.
BEARISH -48
IMTX $1.1B
Immatics N.V.
BEARISH -49
KURA $850M
Kura Oncology, Inc.
BEARISH -49
ATTO $630M
Attovia Therapeutics, Inc.
BEARISH -49
OCS $490M
Oculis Holding AG
BEARISH -49
DYAI $20M
Dyadic International, Inc.
BEARISH -49
DVHGF $20M
Devonian Health Group, Inc.
BEARISH -49
ALLR $10M
Allarity Therapeutics, Inc.
BEARISH -49
SCPS —
Scopus BioPharma Inc.
BEARISH -49
BIORQ —
Biora Therapeutics, Inc.
BEARISH -49
BITRF —
Biotron Limited
BEARISH -49
THER —
Theralink Technologies, Inc.
BEARISH -49
AURA $650M
Aura Biosciences, Inc.
BEARISH -50
TTRX $310M
Turn Therapeutics Inc.
BEARISH -50
ARCT $280M
Arcturus Therapeutics Holdings Inc.
BEARISH -50
SPHRY $220M
Starpharma Holdings Limited
BEARISH -50
BETRF $110M
BetterLife Pharma Inc.
BEARISH -50
NTRB $70M
Nutriband Inc.
BEARISH -50
HRGN $30M
Harvard Apparatus Regenerative Technology Inc.
BEARISH -50
PVCT $20M
Provectus Biopharmaceuticals, Inc.
BEARISH -50
APUS —
Apimeds Pharmaceuticals US, Inc
BEARISH -50
ERNAW —
Ernexa Therapeutics Inc. Warrants
BEARISH -50
RNAZ —
TransCode Therapeutics, Inc.
BEARISH -50
VRPX —
Virpax Pharmaceuticals, Inc.
BEARISH -50
VRAX —
Virax Biolabs Group Limited
BEARISH -50
SCNI —
Scinai Immunotherapeutics Ltd.
BEARISH -50
GHRS $1.2B
GH Research PLC
BEARISH -52
ABUS $830M
Arbutus Biopharma Corp
BEARISH -52
QTTB $260M
Q32 Bio Inc.
BEARISH -52
HOPHF $20M
Hemogenyx Pharmaceuticals Plc
BEARISH -52
ANL $560M
Adlai Nortye Ltd.
BEARISH -53
ARTV $300M
Artiva Biotherapeutics, Inc.
BEARISH -53
PLX $210M
Protalix BioTherapeutics, Inc.
BEARISH -53
FBIOP $130M
Fortress Biotech, Inc.
BEARISH -53
ALZN $10M
Alzamend Neuro Inc
BEARISH -53
AFFY —
Affymax, Inc.
BEARISH -53
XBIO —
Xenetic Biosciences, Inc.
BEARISH -53
PLYX $90M
Polaryx Therapeutics, Inc. Common Stock
BEARISH -55
SYRS —
Syros Pharmaceuticals, Inc.
BEARISH -56
MLYS $1.8B
Mineralys Therapeutics, Inc.
BEARISH -58
GENB $1.6B
Generate Biomedicines, Inc.
BEARISH -58
CMPS $1.6B
COMPASS Pathways plc
BEARISH -58
NKTR $1.1B
Nektar Therapeutics
BEARISH -58
AVBP $1.0B
ArriVent BioPharma, Inc.
BEARISH -58
ALMS $880M
Alumis Inc.
BEARISH -58
SANA $700M
Sana Biotechnology, Inc.
BEARISH -58
FULC $280M
Fulcrum Therapeutics, Inc.
BEARISH -58
IPSC $260M
Century Therapeutics, Inc.
BEARISH -58
TARA $140M
Protara Therapeutics, Inc.
BEARISH -58
OTLK $130M
Outlook Therapeutics, Inc.
BEARISH -58
VERU $40M
Veru Inc.
BEARISH -58
SEOVF $30M
Sernova Corp.
BEARISH -58
SNANF $20M
Sona Nanotech Inc.
BEARISH -58
AKTX $20M
Akari Therapeutics, Plc
BEARISH -58
LTRN $10M
Lantern Pharma Inc.
BEARISH -58
HMTXF $10M
Hemostemix Inc.
BEARISH -58
ADIL $10M
Adial Pharmaceuticals, Inc.
BEARISH -58
ANEB $10M
Anebulo Pharmaceuticals, Inc.
BEARISH -58
PLRZ $10M
Polyrizon Ltd.
BEARISH -58
SNTI $10M
Senti Biosciences, Inc.
BEARISH -58
AMBS —
Amarantus BioScience Holdings, Inc.
BEARISH -58
ANTH —
Anthera Pharmaceuticals, Inc.
BEARISH -58
ATRX —
Adhera Therapeutics Inc
BEARISH -58
SLXN —
Silexion Therapeutics Ltd.
BEARISH -58
LIPO —
Lipella Pharmaceuticals Inc.
BEARISH -58
EVGN —
Evogene Ltd.
BEARISH -58
AMPE —
Ampio Pharmaceuticals, Inc.
BEARISH -58
ORIC $1.4B
ORIC Pharmaceuticals, Inc.
BEARISH -59
IMRN $10M
Immuron Limited
BEARISH -59
BCTXZ —
BriaCell Therapeutics Corp. Warrant
BEARISH -59
ANRO $860M
Alto Neuroscience, Inc.
BEARISH -60
DSGN $640M
Design Therapeutics, Inc.
BEARISH -60
BRIBF $90M
Brii Biosciences Limited
BEARISH -60
ELOX $40M
Eloxx Pharmaceuticals, Inc.
BEARISH -60
AUTL $410M
Autolus Therapeutics plc
BEARISH -62
BVAXF —
BioVaxys Technology Corp.
BEARISH -62
AVLN $1.1B
Avalyn Pharma Inc. Common Stock
BEARISH -65
BCAX $1.1B
Bicara Therapeutics Inc. Common Stock
BEARISH -65
MNKD $1.0B
MannKind Corporation
BEARISH -65
GLUE $920M
Monte Rosa Therapeutics, Inc.
BEARISH -65
WVE $630M
Wave Life Sciences Ltd.
BEARISH -65
LRMR $240M
Larimar Therapeutics, Inc.
BEARISH -65
ALXO $160M
ALX Oncology Holdings Inc.
BEARISH -65
HUMA $120M
Humacyte, Inc.
BEARISH -65
IMUX $100M
Immunic, Inc.
BEARISH -65
ADAG $90M
Adagene Inc.
BEARISH -65
RECEF $70M
Recce Pharmaceuticals Ltd
BEARISH -65
TELO $70M
Telomir Pharmaceuticals, Inc. Common Stock
BEARISH -65
TENX $50M
Tenax Therapeutics, Inc.
BEARISH -65
CVM $30M
CEL-SCI Corporation
BEARISH -65
ARTL $10M
Artelo Biosciences, Inc.
BEARISH -65
FNAM —
Evolutionary Genomics, Inc.
BEARISH -65
WINT —
Windtree Therapeutics, Inc.
BEARISH -65
SYBE —
SYBLEU Inc
BEARISH -65
RGRX —
RegeneRx Biopharmaceuticals, Inc.
BEARISH -65
BICTF —
Biocure Technology Inc.
BEARISH -65
INVA $1.5B
Innoviva, Inc.
BEARISH -66
ACHV $670M
Achieve Life Sciences, Inc.
BEARISH -66
EIKN $390M
Eikon Therapeutics, Inc. Common Stock
BEARISH -66
TECX $390M
Tectonic Therapeutic, Inc.
BEARISH -66
CLVLF $250M
Clinuvel Pharmaceuticals Limited
BEARISH -66
RNAC $190M
Cartesian Therapeutics, Inc.
BEARISH -66
NAGE $190M
Niagen Bioscience Inc
BEARISH -66
VRXA $140M
Veraxa Biotech Holding AG
BEARISH -66
TNXP $90M
Tonix Pharmaceuticals Holding Corp.
BEARISH -66
GNLX $90M
Genelux Corporation
BEARISH -66
CNXU $90M
Conexeu Sciences Inc.
BEARISH -66
INO $60M
Inovio Pharmaceuticals, Inc.
BEARISH -66
ONCY $50M
Oncolytics Biotech Inc.
BEARISH -66
NDTP $50M
NDT Pharmaceuticals Inc.
BEARISH -66
CLCS $40M
Cell Source, Inc.
BEARISH -66
RVXCF $20M
Resverlogix Corp.
BEARISH -66
NEUP $20M
Neuphoria Therapeutics Inc.
BEARISH -66
CNTX $20M
Context Therapeutics Inc.
BEARISH -66
LPCN $10M
Lipocine Inc.
BEARISH -66
ICU $10M
SeaStar Medical Holding Corporation
BEARISH -66
PHIO $10M
Phio Pharmaceuticals Corp.
BEARISH -66
CDT —
CDT Equity Inc.
BEARISH -66
BRTX —
BioRestorative Therapies, Inc.
BEARISH -66
BBLG —
Bone Biologics Corporation
BEARISH -66
AFMDQ —
Affimed N.V.
BEARISH -66
SXTP —
60 Degrees Pharmaceuticals, Inc.
BEARISH -66
SPRC —
SciSparc Ltd.
BEARISH -66
MTNB —
Matinas BioPharma Holdings, Inc.
BEARISH -66
BLEG —
Branded Legacy, Inc.
BEARISH -66
GRI —
GRI Bio, Inc.
BEARISH -66
VCNX —
Vaccinex, Inc.
BEARISH -66
LNAI —
Lunai Bioworks Inc.
BEARISH -66
DRMA —
Dermata Therapeutics, Inc.
BEARISH -66
VIVS —
VivoSim Labs, Inc.
BEARISH -66
LITS $40M
Lite Strategy, Inc.
BEARISH -68
DRTS $1.2B
Alpha Tau Medical Ltd
BEARISH -69
SLDB $630M
Solid Biosciences Inc.
BEARISH -69
ORMP $170M
Oramed Pharmaceuticals Inc.
BEARISH -69
AMGXF $140M
AnGes, Inc.
BEARISH -69
ANTX $130M
AN2 Therapeutics, Inc.
BEARISH -69
BBIXF $50M
Bonus BioGroup Ltd.
BEARISH -69
INTI $10M
Inhibitor Therapeutics, Inc.
BEARISH -69
RMTG —
Regenerative Medical Technology Group Inc.
BEARISH -69
MYMX —
Mymetics Corporation
BEARISH -69
NWPHF $410M
Newron Pharmaceuticals S.p.A.
BEARISH -71
VRXAW —
Veraxa Biotech AG
BEARISH -71
SRNE —
Sorrento Therapeutics, Inc.
BEARISH -73
OLMA $560M
Olema Pharmaceuticals, Inc.
BEARISH -74
CBIO $480M
Crescent Biopharma, Inc.
BEARISH -74
BLSM $430M
BlossomHill Therapeutics, Inc.
BEARISH -74
GOSS $60M
Gossamer Bio, Inc.
BEARISH -74
IBO $30M
Impact BioMedical Inc.
BEARISH -74
AIM $10M
AIM ImmunoTech Inc.
BEARISH -74
LGVN —
Longeveron Inc.
BEARISH -74
BTAIQ —
BioXcel Therapeutics, Inc.
BEARISH -74
SILO —
Silo Pharma, Inc.
BEARISH -74
AAPG $1.4B
Ascentage Pharma Group International
BEARISH -75
OMER $1.2B
Omeros Corporation
BEARISH -75
ASCLF $770M
Ascletis Pharma Inc.
BEARISH -75
NVCT $650M
Nuvectis Pharma, Inc.
BEARISH -75
FDMT $600M
4D Molecular Therapeutics, Inc.
BEARISH -75
PHAT $460M
Phathom Pharmaceuticals, Inc.
BEARISH -75
EPRX $450M
Eupraxia Pharmaceuticals Inc.
BEARISH -75
AGEN $290M
Agenus Inc.
BEARISH -75
GALT $210M
Galectin Therapeutics Inc.
BEARISH -75
CGEN $180M
Compugen Ltd.
BEARISH -75
SEER $110M
Seer, Inc.
BEARISH -75
VANI $100M
Vivani Medical, Inc.
BEARISH -75
COYA $90M
Coya Therapeutics, Inc.
BEARISH -75
MNOV $70M
MediciNova, Inc.
BEARISH -75
PMVP $70M
PMV Pharmaceuticals, Inc.
BEARISH -75
OSTX $60M
OS Therapies Incorporated
BEARISH -75
HRTX $60M
Heron Therapeutics, Inc.
BEARISH -75
SPRO $60M
Spero Therapeutics, Inc.
BEARISH -75
XLO $50M
Xilio Therapeutics, Inc.
BEARISH -75
ALPS $50M
Alps Group Inc
BEARISH -75
MREO $40M
Mereo BioPharma Group plc
BEARISH -75
CRVO $30M
CervoMed Inc.
BEARISH -75
COCP $20M
Cocrystal Pharma, Inc.
BEARISH -75
PHYOF $10M
IXICO plc
BEARISH -75
OTLC $10M
Oncotelic Therapeutics, Inc.
BEARISH -75
GLWLF $10M
Glow Lifetech Corp.
BEARISH -75
PASG $10M
Passage Bio, Inc.
BEARISH -75
KPRX $10M
Kiora Pharmaceuticals, Inc.
BEARISH -75
ADTX —
Aditxt, Inc.
BEARISH -75
EVLO —
Evelo Biosciences, Inc.
BEARISH -75
ISCO —
International Stem Cell Corporation
BEARISH -75
ELAB —
PMGC Holdings Inc.
BEARISH -75
YECO —
EV Biologics, Inc.
BEARISH -75
HMGN —
Hemagen Diagnostics, Inc.
BEARISH -75
CHMMF —
Chimeric Therapeutics Limited
BEARISH -75
CVKD —
Cadrenal Therapeutics, Inc. Common Stock
BEARISH -75
AGNPF —
Grey Matters Health Inc.
BEARISH -75
MAJI —
Nextel Medical Corp.
BEARISH -75
LIMNW —
Liminatus Pharma, Inc. Warrants
BEARISH -75
RGBPP —
Regen BioPharma, Inc.
BEARISH -75
NVAX $1.6B
Novavax, Inc.
BEARISH -78
NUVB $1.6B
Nuvation Bio Inc.
BEARISH -78
MGTX $880M
MeiraGTx Holdings plc
BEARISH -78
LXRX $630M
Lexicon Pharmaceuticals, Inc.
BEARISH -78
CLYM $590M
Climb Bio, Inc.
BEARISH -78
MDXG $570M
MiMedx Group, Inc.
BEARISH -78
MNPR $470M
Monopar Therapeutics Inc.
BEARISH -78
AVIR $320M
Atea Pharmaceuticals, Inc.
BEARISH -78
PRQR $180M
ProQR Therapeutics N.V.
BEARISH -78
PYXS $110M
Pyxis Oncology, Inc.
BEARISH -78
INMB $40M
INmune Bio, Inc.
BEARISH -78
BMEA $40M
Biomea Fusion, Inc.
BEARISH -78
CELU $30M
Celularity Inc.
BEARISH -78
TVGN $30M
Tevogen Bio Holdings Inc.
BEARISH -78
AVEFF $20M
Avecho Biotechnology Limited
BEARISH -78
SER $20M
Serina Therapeutics, Inc.
BEARISH -78
SYBX $10M
Synlogic, Inc.
BEARISH -78
CMMB $10M
Chemomab Therapeutics Ltd.
BEARISH -78
XRTX —
XORTX Therapeutics Inc.
BEARISH -78
XTLB —
XTL Biopharmaceuticals Ltd.
BEARISH -78
OZYMF —
Strategic Partners A/S
BEARISH -78
GNLKQ —
GeneLink, Inc.
BEARISH -78
GLABF —
Gemina Laboratories Ltd.
BEARISH -78
HXBM —
Helix BioMedix, Inc.
BEARISH -78
KRSA $150M
Korsana Biosciences, Inc.
BEARISH -80
HBMHF $1.3B
HBM Holdings Limited
BEARISH -82
GERN $720M
Geron Corporation
BEARISH -82
SLBT $640M
SL Science Holding Ltd
BEARISH -82
GYRE $620M
Gyre Therapeutics, Inc.
BEARISH -82
ANNX $610M
Annexon, Inc.
BEARISH -82
AGMB $450M
AgomAb Therapeutics N.V. American Depositary Shares
BEARISH -82
ASMB $400M
Assembly Biosciences, Inc.
BEARISH -82
RLMD $350M
Relmada Therapeutics, Inc.
BEARISH -82
MPLT $340M
MapLight Therapeutics, Inc.
BEARISH -82
CTNM $270M
Contineum Therapeutics, Inc.
BEARISH -82
LXEO $230M
Lexeo Therapeutics, Inc. Common Stock
BEARISH -82
BOVNF $220M
BioInvent International AB (publ)
BEARISH -82
BBOT $210M
BridgeBio Oncology Therapeutics Inc.
BEARISH -82
MENS $130M
Jyong Biotech Ltd. Ordinary Shares
BEARISH -82
MIST $80M
Milestone Pharmaceuticals Inc.
BEARISH -82
NMRA $70M
Neumora Therapeutics, Inc. Common Stock
BEARISH -82
HBPCF $60M
Helix BioPharma Corp.
BEARISH -82
IMA $50M
ImageneBio Inc
BEARISH -82
PRRUF $20M
Immutep Limited
BEARISH -82
CLRB $10M
Cellectar Biosciences, Inc.
BEARISH -82
ARNI —
Arno Therapeutics, Inc.
BEARISH -82
BIOAF —
Bioasis Technologies Inc.
BEARISH -82
ENLV —
Enlivex Therapeutics Ltd.
BEARISH -82
MYNDF —
MYND Life Sciences Inc.
BEARISH -82
SEPSF —
Asep Medical Holdings Inc
BEARISH -82
ARUXF —
Acrux Limited
BEARISH -82
ZVRA $580M
Zevra Therapeutics, Inc.
BEARISH -84
IRD $290M
Opus Genetics, Inc.
BEARISH -84
CUE $140M
Cue Biopharma, Inc.
BEARISH -84
MGNX $140M
MacroGenics, Inc.
BEARISH -84
ACRV $70M
Acrivon Therapeutics, Inc. Common Stock
BEARISH -84
SKYE $10M
Skye Bioscience, Inc.
BEARISH -84
PTIX —
Protagenic Therapeutics, Inc.
BEARISH -84
EMMA —
Emmaus Life Sciences, Inc.
BEARISH -84
PHRRF —
PharmaTher Holdings Ltd.
BEARISH -84
RVLPQ —
RVL Pharmaceuticals plc
BEARISH -84
URGN $1.7B
UroGen Pharma Ltd.
BEARISH -87
MDCLF $1.1B
MedinCell S.A.
BEARISH -87
IMMX $680M
Immix Biopharma, Inc.
BEARISH -87
CADL $610M
Candel Therapeutics, Inc.
BEARISH -87
GNFTF $470M
Genfit S.A.
BEARISH -87
IKT $220M
Inhibikase Therapeutics, Inc.
BEARISH -87
TRGNF $120M
Transgene S.A.
BEARISH -87
PRNAF $50M
Alterity Therapeutics Limited
BEARISH -87
BOLD $50M
Boundless Bio, Inc.
BEARISH -87
BMNDF $20M
Biomind Labs Inc.
BEARISH -87
PBM —
Psyence Biomedical Ltd.
BEARISH -87
GENSF $1.8B
Genus plc
BEARISH -91
OCUL $1.4B
Ocular Therapeutix, Inc.
BEARISH -91
GPCR $1.2B
Structure Therapeutics Inc.
BEARISH -91
SNDX $1.2B
Syndax Pharmaceuticals, Inc.
BEARISH -91
AKTS $850M
Aktis Oncology, Inc.
BEARISH -91
ARDX $770M
Ardelyx, Inc.
BEARISH -91
CTMX $510M
CytomX Therapeutics, Inc.
BEARISH -91
PROK $470M
ProKidney Corp.
BEARISH -91
FTH $440M
Faeth Therapeutics, Inc.
BEARISH -91
ALLO $430M
Allogene Therapeutics, Inc.
BEARISH -91
AVCTF $420M
Avacta Group Plc
BEARISH -91
SPRY $400M
ARS Pharmaceuticals, Inc.
BEARISH -91
CAPR $340M
Capricor Therapeutics, Inc.
BEARISH -91
KYTX $330M
Kyverna Therapeutics, Inc.
BEARISH -91
SPHDF $280M
Santhera Pharmaceuticals Holding AG
BEARISH -91
ORYZF $250M
Oryzon Genomics S.A.
BEARISH -91
OCGN $250M
Ocugen, Inc.
BEARISH -91
ABEO $250M
Abeona Therapeutics Inc.
BEARISH -91
VNDA $240M
Vanda Pharmaceuticals Inc.
BEARISH -91
HLOSF $240M
Healios K.K.
BEARISH -91
IPHYF $210M
Innate Pharma S.A.
BEARISH -91
BIOA $190M
BioAge Labs Inc.
BEARISH -91
EVMN $190M
Evommune, Inc.
BEARISH -91
NBP $160M
NovaBridge Biosciences
BEARISH -91
SION $160M
Sionna Therapeutics, Inc.
BEARISH -91
AKBA $160M
Akebia Therapeutics, Inc.
BEARISH -91
ZNTL $160M
Zentalis Pharmaceuticals, Inc.
BEARISH -91
NGEN $150M
NervGen Pharma Corp. Common stock
BEARISH -91
CNTN $150M
Canton Strategic Holdings Inc
BEARISH -91
STRO $150M
Sutro Biopharma, Inc.
BEARISH -91
CDXS $140M
Codexis, Inc.
BEARISH -91
NKTX $130M
Nkarta, Inc.
BEARISH -91
AVXL $120M
Anavex Life Sciences Corp.
BEARISH -91
CBUS $110M
Cibus, Inc.
BEARISH -91
VXRT $100M
Vaxart, Inc.
BEARISH -91
CLLS $100M
Cellectis S.A.
BEARISH -91
ORPOF $100M
OSE Immunotherapeutics S.A.
BEARISH -91
TNYA $90M
Tenaya Therapeutics, Inc.
BEARISH -91
CRBP $80M
Corbus Pharmaceuticals Holdings, Inc.
BEARISH -91
JWCTF $80M
JW (Cayman) Therapeutics Co. Ltd
BEARISH -91
CRDF $70M
Cardiff Oncology, Inc.
BEARISH -91
CGTX $70M
Cognition Therapeutics, Inc.
BEARISH -91
CRBU $60M
Caribou Biosciences, Inc.
BEARISH -91
IBIO $50M
iBio, Inc.
BEARISH -91
HYFT $50M
MindWalk Holdings Corp.
BEARISH -91
VTIAF $50M
FamiCord AG
BEARISH -91
CNTB $50M
Connect Biopharma Holdings Limited
BEARISH -91
EXOZ $40M
eXoZymes, Inc.
BEARISH -91
TIL $40M
Instil Bio, Inc.
BEARISH -91
ALDX $40M
Aldeyra The
BEARISH -91
ANVS $40M
Annovis Bio, Inc.
BEARISH -91
DWTX $40M
Dogwood Therapeutics, Inc.
BEARISH -91
RANI $40M
Rani Therapeutics Holdings, Inc.
BEARISH -91
IGC $30M
IGC Pharma, Inc.
BEARISH -91
IXHL $30M
Incannex Healthcare Limited
BEARISH -91
GRCE $30M
Grace Therapeutics, Inc.
BEARISH -91
FLNA $30M
Filana Therapeutics, Inc.
BEARISH -91
BCTX $30M
BriaCell Therapeutics Corp.
BEARISH -91
MVMDF $20M
More Life Company Corp.
BEARISH -91
BYSI $20M
BeyondSpring Inc.
BEARISH -91
ATYR $20M
aTyr Pharma, Inc.
BEARISH -91
BLRX $10M
BioLineRx Ltd.
BEARISH -91
INAB $10M
IN8bio, Inc.
BEARISH -91
QNRX $10M
Quoin Pharmaceuticals, Ltd.
BEARISH -91
RDTCF $10M
Rapid Dose Therapeutics Corp.
BEARISH -91
OPTBF $10M
OptiBiotix Health Plc
BEARISH -91
MSLE $10M
Satellos Bioscience Inc.
BEARISH -91
VTGN $10M
VistaGen Therapeutics, Inc.
BEARISH -91
TPST $10M
Tempest Therapeutics, Inc.
BEARISH -91
CDIO $10M
Cardio Diagnostics Holdings, Inc.
BEARISH -91
TRAW $10M
Traws Pharma, Inc.
BEARISH -91
APRE $10M
Aprea Therapeutics, Inc.
BEARISH -91
PTN $10M
Palatin Technologies, Inc.
BEARISH -91
GUTS $10M
Fractyl Health, Inc.
BEARISH -91
TOVX $10M
Theriva Biologics, Inc.
BEARISH -91
TCRX $10M
TScan Therapeutics, Inc.
BEARISH -91
TVRD $10M
Tvardi Therapeutics, Inc.
BEARISH -91
KTTA $10M
Pasithea Therapeutics Corp.
BEARISH -91
GTBP $10M
GT Biopharma, Inc.
BEARISH -91
PXXLF $10M
Poxel S.A.
BEARISH -91
DARE $10M
Dare Bioscience, Inc.
BEARISH -91
GSGTF $10M
GenSight Biologics S.A.
BEARISH -91
QNTM $10M
Quantum BioPharma Ltd.
BEARISH -91
INTS $10M
Intensity Therapeutics, Inc.
BEARISH -91
IMNN $10M
Imunon, Inc.
BEARISH -91
SUVZ —
Suvanza Pharma, LLC
BEARISH -91
HCWB —
HCW Biologics Inc.
BEARISH -91
LIFS —
Life Stem Genetics Inc.
BEARISH -91
RADX —
Radiopharm Theranostics Limited
BEARISH -91
MBAI —
MBody AI Ltd.
BEARISH -91
APVO —
Aptevo Therapeutics Inc.
BEARISH -91
KAPA —
Kairos Pharma, Ltd.
BEARISH -91
DCOY —
Decoy Therapeutics Inc.
BEARISH -91
ENZC —
Enzolytics Inc.
BEARISH -91
RASP —
Actavia Life Sciences, Inc.
BEARISH -91
EVFM —
Evofem Biosciences, Inc.
BEARISH -91
CLDI —
Calidi Biotherapeutics, Inc.
BEARISH -91
MBIO —
Mustang Bio, Inc.
BEARISH -91
LIMN —
Liminatus Pharma, Inc. Class A Common Stock
BEARISH -91
KALA —
KALA BIO, Inc.
BEARISH -91
TSOI —
Therapeutic Solutions International, Inc.
BEARISH -91
WSNAF —
Wesana Health Holdings Inc.
BEARISH -91
GNPX —
Genprex, Inc.
BEARISH -91
NCEL —
NewcelX Ltd.
BEARISH -91
OGEN —
Oragenics, Inc.
BEARISH -91
NBRVF —
Nabriva Therapeutics plc
BEARISH -91
BNIGF —
Beroni Group Limited
BEARISH -91
ZVSA —
ZyVersa Therapeutics, Inc.
BEARISH -91
NIKI —
Niki BioSolutions, Inc.
BEARISH -91
GOVX —
GeoVax Labs, Inc.
BEARISH -91
VBIO —
Valion Bio, Inc.
BEARISH -91
AXIM —
AXIM Biotechnologies, Inc.
BEARISH -91
TNGNQ —
Tengion, Inc.
BEARISH -91
XENO —
Xeno Transplants Corporation
BEARISH -91
ZHCLF —
Zenith Capital Corp.
BEARISH -91
MLECW —
Moolec Science S.A.
BEARISH -91
MDCX —
Medicus Pharma Ltd. Common Stock
BEARISH -91
VPRO —
Viropro Inc.
BEARISH -91
IVEVF $750M
Inventiva S.A.
BEARISH -100
RGNX $440M
REGENXBIO Inc.
BEARISH -100
ALT $410M
Altimmune, Inc.
BEARISH -100
AVTX $370M
Avalo Therapeutics, Inc.
BEARISH -100
DMTRF $310M
3-D Matrix, Ltd.
BEARISH -100
CABA $250M
Cabaletta Bio, Inc.
BEARISH -100
ACIU $250M
AC Immune S.A.
BEARISH -100
SCTX $250M
Scribe Therapeutics Inc.
BEARISH -100
PALI $230M
Palisade Bio, Inc.
BEARISH -100
IVVD $180M
Invivyd, Inc.
BEARISH -100
UPB $150M
Upstream Bio, Inc.
BEARISH -100
CMPX $140M
Compass Therapeutics, Inc.
BEARISH -100
VYGR $110M
Voyager Therapeutics, Inc.
BEARISH -100
NERV $110M
Minerva Neurosciences, Inc.
BEARISH -100
VTVT $100M
vTv Therapeutics Inc.
BEARISH -100
LENZ $100M
LENZ Therapeutics, Inc.
BEARISH -100
ENGN $100M
enGene Holdings Inc.
BEARISH -100
PTHS $70M
Pelthos Therapeutics Inc.
BEARISH -100
TLSA $60M
Tiziana Life Sciences Ltd
BEARISH -100
VRCA $60M
Verrica Pharmaceuticals Inc.
BEARISH -100
XBIT $60M
XBiotech Inc.
BEARISH -100
GANX $50M
Gain Therapeutics, Inc.
BEARISH -100
PLRX $50M
Pliant Therapeutics, Inc.
BEARISH -100
KLRS $40M
Kalaris Therapeutics Inc
BEARISH -100
ACET $40M
Adicet Bio, Inc.
BEARISH -100
NRXBF $30M
NurExone Biologic Inc.
BEARISH -100
EYPT $30M
EyePoint Pharmaceuticals, Inc.
BEARISH -100
ALGS $30M
Aligos Therapeutics, Inc.
BEARISH -100
EDSA $30M
Edesa Biotech, Inc.
BEARISH -100
AARD $30M
Aardvark Therapeutics, Inc. Common Stock
BEARISH -100
MGX $30M
Metagenomi, Inc. Common Stock
BEARISH -100
BSEM $30M
BioStem Technologies, Inc.
BEARISH -100
TELIF $20M
Telescope Innovations Corp.
BEARISH -100
MCRB $20M
Seres Therapeutics, Inc.
BEARISH -100
KYNB $20M
Kyntra Bio, Inc.
BEARISH -100
BXPHF $20M
Botanix Pharmaceuticals Limited
BEARISH -100
ACTU $10M
Actuate Therapeutics Inc
BEARISH -100
FBLG $10M
FibroBiologics, Inc. Common Stock
BEARISH -100
AIMD $10M
Ainos, Inc.
BEARISH -100
ACXP $10M
Acurx Pharmaceuticals, Inc.
BEARISH -100
BCDA $10M
BioCardia, Inc.
BEARISH -100
HIND $10M
Vyome Holdings, Inc.
BEARISH -100
MTVA $10M
MetaVia Inc.
BEARISH -100
RVPH $10M
Reviva Pharmaceuticals Holdings, Inc.
BEARISH -100
CODX —
Co-Diagnostics, Inc.
BEARISH -100
NAVBQ —
Navidea Biopharmaceuticals, Inc.
BEARISH -100
LABT —
Lakewood-Amedex Biotherapeutics, Inc.
BEARISH -100
FAMDF —
Futura Medical plc
BEARISH -100
NSHSF —
NanoSphere Health Sciences Inc.
BEARISH -100
CANF —
Can-Fite BioPharma Ltd.
BEARISH -100
PPBT —
Purple Biotech Ltd.
BEARISH -100
NRSN —
NeuroSense Therapeutics Ltd.
BEARISH -100
NMLSF —
Restart Life Sciences Corp.
BEARISH -100
ZLDAF —
Zelira Therapeutics Limited
BEARISH -100
PMCB —
PharmaCyte Biotech, Inc.
BEARISH -100
SCPX —
Scorpius Holdings, Inc.
BEARISH -100
CELZ —
Creative Medical Technology Holdings, Inc.
BEARISH -100
CRIS —
Curis, Inc.
BEARISH -100
OXBOF —
Oxford BioDynamics Plc
BEARISH -100
XSNX —
NovAccess Global Inc.
BEARISH -100

Peer Comparison

Symbol Mkt Cap P/E ROE % ROIC % Net Mgn % Rev Grw % Piotroski Signal 1Y Ret %
UNCY Unicycive Therapeutics, Inc. $110M -2.1 -101.1 349.9 — — 4 BEARISH -29.6
SEPN Septerna Inc $1.9B -81.5 -6.3 -93.1 -48.7 17878.5 5 BULLISH 103.7
COAG Hemab Therapeutics Holdings, Inc. Common Stock $1.6B — — — — — — BULLISH —
VSTM Verastem, Inc. $910M -4.1 -471.2 6197.3 -86.5 3995.7 4 BULLISH 27.0
SOLTF Nxera Pharma Co., Ltd. $770M -15.8 -12.0 -1.7 -2.6 7.5 4 BULLISH 38.2
PYPD PolyPid Ltd. $110M -3.9 -1913.8 231.6 — — 3 BULLISH 67.7
ANIX Anixa Biosciences, Inc. $100M -10.7 -67.1 -1110.2 — — 3 BULLISH -20.8
GRDX GridAI Technologies Corp. $40M -1.4 -55.6 -51.7 -14927.4 67.4 2 BULLISH 44.5
KLRA Kailera Therapeutics, Inc. $1.7B — — — — — — BULLISH —
SPTX Seaport Therapeutics, Inc. Common Stock $1.1B — — — — — — BULLISH —
SGP SpyGlass Pharma, Inc. Common Stock $950M — — — — — — BULLISH —
ENTX Entera Bio Ltd. $510M -8.8 -138.9 314.4 — -100.0 1 BULLISH 37.8
ATNM Actinium Pharmaceuticals, Inc. $50M 4.0 45.9 -197.8 79.7 — 3 BULLISH -15.0
PRME Prime Medicine, Inc. $670M -4.0 -373.3 -271.3 -3649.0 -17.9 3 BULLISH -18.4
XFOR X4 Pharmaceuticals, Inc. $320M -2.7 -113.1 -281.1 -183.5 -51.6 4 BULLISH -14.5
CING Cingulate Inc. $70M -1.1 -198.7 -1452.8 — — 4 BULLISH 43.3
ESLA Estrella Immunopharma, Inc. $40M -3.8 148.1 102.1 — — 3 BULLISH -60.8
INDP Indaptus Therapeutics, Inc. $360M -0.5 -318.0 6437.4 — — 4 BULLISH -8.8
KRRO Korro Bio, Inc. $180M -1.3 -97.7 -196.6 — -62.1 2 BULLISH -65.1
VIR Vir Biotechnology, Inc. $1.8B -6.2 -26.1 -38.8 33.5 1495.9 5 BULLISH 93.5
MAZE Maze Therapeutics, Inc. $1.7B -11.4 -37.3 -112.3 — — 3 BULLISH 4.3
ZIVO ZIVO Bioscience, Inc. $20M -4.5 185.9 147.5 — -62.5 2 BULLISH -53.1
LBRX LB Pharmaceuticals Inc Common Stock $1.2B -13.4 -25.8 -768.9 — — 2 BULLISH 148.2
OABIW OmniAb, Inc. $1.1B -13.8 -16.9 -16.8 -43.7 66.9 6 BULLISH -17.6
RIGL Rigel Pharmaceuticals, Inc. $900M 2.8 126.9 88.5 22.0 3.3 4 BULLISH 68.7
MXCT MaxCyte, Inc. $140M -4.7 -20.4 -38.9 -122.0 -13.2 2 BULLISH -5.5
HURA TuHURA Biosciences, Inc. $140M -3.8 -161.4 -137.6 — — 2 BULLISH -7.9
IRLA IRulya Therapeutics Inc. $30M — — — — — — BULLISH —
LYEL Lyell Immunopharma, Inc. $230M -0.6 -93.3 -227.7 -1118875.0 -55.0 3 BULLISH -42.6
AGTX Agentix Corp. — -5.1 12.0 8.1 — — 3 BULLISH 6.9
NAUT Nautilus Biotechnolgy, Inc. $410M -6.5 -41.0 -89.2 -6682.1 — 2 BULLISH 136.9
RARE Ultragenyx Pharmaceutical Inc. $1.5B -2.9 839.4 -67.5 -43.0 17.5 2 BULLISH -50.0
XNCR Xencor, Inc. $1.9B -13.7 -29.1 -152.4 -42.4 -36.1 2 BULLISH 127.0
TRAX First Tracks Biotherapeutics Inc $1.6B — — — — — — BULLISH —
SLN Silence Therapeutics plc $930M -5.2 -90.4 157.8 — -97.6 1 BULLISH 171.0
PBYI Puma Biotechnology, Inc. $570M 20.3 22.0 52.8 14.5 -2.9 6 BULLISH 108.8
SGMT Sagimet Biosciences Inc. $310M -8.2 -24.4 -231.4 — — 3 BULLISH 14.0
HOWL Werewolf Therapeutics, Inc. $50M -1.4 -119.9 354.7 17.5 — 4 BULLISH -41.2
NNVC NanoViricides, Inc. $40M -3.6 -101.5 -111.4 — — 3 BULLISH -4.6
MBRX Moleculin Biotech, Inc. $10M -0.0 -1371.6 -494.1 — — 3 BULLISH -23.7
AZTR Azitra, Inc. — -0.1 -256.7 -959.6 — — 5 BULLISH 94.8
NBTX Nanobiotix S.A. $1.5B -27.5 104.2 62.0 -626.0 49.1 4 BULLISH 79.8
BOLT Bolt Biotherapeutics, Inc. $10M -0.4 -111.6 -138.8 -154400.0 12.8 3 BULLISH 6.2
BDRX Biodexa Pharmaceuticals Plc — -0.1 -42.3 -117.9 — — 2 BULLISH -89.1
CBDG THC Farmaceuticals, Inc. — -30.9 2.0 -0.9 — 28.1 5 BULLISH -63.1
NTLA Intellia Therapeutics, Inc. $1.6B -3.6 -55.4 -92.1 -1392.3 12.6 5 BULLISH -52.0
PHAR Pharming Group N.V. $710M 81.8 3.6 3.2 1.8 7.8 7 BULLISH -12.7
PCSA Processa Pharmaceuticals, Inc. $10M -0.3 -464.2 1977.5 — — 2 BULLISH -76.5
ICCC ImmuCell Corporation $90M 124.9 2.6 10.2 25.5 8.5 6 BULLISH 68.8
PLUR Pluri Inc. $10M -0.5 163.6 -483.9 -1755.2 -24.0 2 BULLISH -69.5
CASBF CanSino Biologics Inc. $1.4B 367.7 0.8 -1.2 11.0 32.5 7 BULLISH -25.5
REPL Replimune Group, Inc. $1.1B -4.2 -134.3 -1055.2 — — 1 BULLISH 48.3
PPCB Propanc Biopharma, Inc. — -0.1 -161.9 -166.7 — — 4 BULLISH 59.9
HALB Halberd Corporation — -25.4 11.6 12.4 — -52.1 1 BULLISH -13.9
ABSI Absci Corporation $1.6B -13.4 -57.7 -213.1 -10443.4 -62.3 5 BULLISH 147.5
CRMD CorMedix Inc. $610M 3.3 54.9 57.2 25.5 280.5 5 BULLISH -28.4
DTIL Precision BioSciences, Inc. $180M -2.4 -135.1 203.1 — 3473.0 5 BULLISH 1.0
NRXS NeurAxis, Inc. $90M -9.6 -143.2 464.1 -118.1 65.2 6 BULLISH 110.9
OKYO OKYO Pharma Limited $70M -6.1 -263.8 88.0 — — 3 BULLISH -37.7
XERS Xeris Biopharma Holdings, Inc. $1.9B -107.0 118.2 18.3 -33.8 36.3 6 BULLISH 13.5
ADCT ADC Therapeutics S.A. $180M -2.4 45.3 260.9 -86.1 2.0 2 BULLISH -61.1
SCNLF Scancell Holdings plc $170M -5.1 153.2 179.2 — -100.0 2 BULLISH 969.8
ZEOX Zeo ScientifiX, Inc. $10M -2.0 -140.0 105.8 -5.6 — 2 BULLISH —
CLGN CollPlant Biotechnologies Ltd. — -0.4 -162.0 -369.3 -2524.1 -86.8 2 BULLISH -82.9
VOR Vor Biopharma Inc. $990M 0.1 -73.6 22.2 — — 3 BULLISH -28.1
ALEC Alector, Inc. $200M -1.9 -385.1 66.8 -692.5 -82.9 1 BULLISH 40.0
ACUT Accustem Sciences Inc. — -1.4 49.7 34.0 -256.7 2610.7 4 BULLISH -88.8
KNBIF Kane Biotech Inc. — -2.4 439.7 -2166.6 -10238.1 -97.9 2 BULLISH -27.9
RXRX Recursion Pharmaceuticals, Inc. $2.0B -3.9 -56.6 -99.7 -1708.0 -14.9 4 BULLISH -33.0
KROS Keros Therapeutics, Inc. $220M -3.1 -17.2 -392.2 — -93.6 3 BULLISH -24.0
TXTM ProText Mobility, Inc. $90M 90.0 -0.4 -0.3 — -100.0 1 BULLISH 273.9
IMCR Immunocore Holdings plc $1.6B -176.2 -2.3 -472.0 -0.7 13.4 4 BULLISH -3.4
DMAC DiaMedica Therapeutics Inc. $470M -11.9 -114.6 616.3 — — 2 BULLISH 26.3
DMRA Damora Therapeutics, Inc. $1.3B — — — — — — BULLISH —
MLTX MoonLake Immunotherapeutics $1.0B -3.1 -67.4 2902.7 — — 1 BULLISH 25.3
PDSB PDS Biotechnology Corporation $60M -2.1 -544.0 456.9 — — 1 BULLISH 41.4
NYMXF Nymox Pharmaceutical Corporation $10M -0.9 193.9 89.4 — — 2 BULLISH -63.2
IPIX Innovation Pharmaceuticals Inc. — -0.2 -115.7 -377.9 — -133.3 3 BULLISH -25.0
PULM Pulmatrix, Inc. $10M -1.3 -98.3 -835.1 — -100.0 3 BULLISH -69.2
TCRT Alaunos Therapeutics, Inc. $10M -1.1 -185.9 -607.2 — -50.0 1 BULLISH -26.9
EDIT Editas Medicine, Inc. $370M -3.4 -118.8 71.4 -153.3 20.8 4 BULLISH -30.1
PEPG PepGen Inc. $170M -1.7 -75.5 -327.5 — — 4 BULLISH -43.1
NGNE Neurogene Inc. $370M -4.9 -45.3 -111469.0 — — 2 LEAN BULL -9.7
LCTX Lineage Cell Therapeutics, Inc. $250M -7.3 -59.0 -171.3 138.6 19.9 5 LEAN BULL -39.4
BCYC Bicycle Therapeutics plc $250M -1.4 -32.3 -1197.0 -8002.1 217.4 4 LEAN BULL -52.0
ABOS Acumen Pharmaceuticals, Inc. $140M -1.5 -162.7 466.8 — — 2 LEAN BULL 2.3
IUGNF Imugene Limited $30M -0.1 -389.5 -458.5 — -100.0 1 LEAN BULL -74.0
INFIQ Infinity Pharmaceuticals, Inc. — -0.0 109.5 60.9 -1707.7 — 2 LEAN BULL 0.0
ARDS Aridis Pharmaceuticals, Inc. — -0.0 4.8 10.0 -19.9 2227.6 4 LEAN BULL -92.3
BSSP Baseline Productions, Inc. — -0.0 167.7 64.9 — — 2 LEAN BULL 100.0
PTCHF PureTech Health plc $390M 157.1 0.2 50.8 1890.6 7.7 4 LEAN BULL -5.4
OBIO Orchestra BioMed Holdings, Inc. $340M -5.6 -397.3 468.3 -26994.3 986.1 4 LEAN BULL 46.0
ACOG Alpha Cognition Inc $130M -8.1 -55.3 -198.4 -144.3 232.7 2 LEAN BULL 11.1
CKDXF Ceryvyn Therapeutics Ltd $10M 0.1 -243.9 2882.8 — -97.3 3 LEAN BULL -97.6
PRVCF PreveCeutical Medical Inc. $10M -16.7 9.9 96.4 — — 3 LEAN BULL -44.7
CYYNF Cynata Therapeutics Limited — -0.3 -326.4 584.9 — -100.0 1 LEAN BULL -93.9
EFTR eFFECTOR Therapeutics, Inc. — -0.0 1737.6 607.9 — -91.9 4 LEAN BULL 300.0
CALA Calithera Biosciences, Inc. — -0.0 -141.5 979.6 — -100.0 1 LEAN BULL 200.0
ENSC Ensysce Biosciences, Inc. $10M -0.2 -968.3 792.9 -220.8 -77.6 3 LEAN BULL -79.8
NTRR Neutra Corp. — 2.0 -139.6 -802.5 -3.8 142.2 7 LEAN BULL -33.3
STOK Stoke Therapeutics, Inc. $1.6B -7.8 -61.1 -318.5 -660.8 -86.2 2 LEAN BULL -19.1
CCCC C4 Therapeutics, Inc. $380M -3.2 -48.1 -175.0 -355.9 2.3 4 LEAN BULL 31.0
ZURA Zura Bio Limited $320M -3.8 -65.4 806.5 — — 2 LEAN BULL 15.7
BIVI BioVie Inc. $10M -0.4 -0.0 -0.0 — — 3 LEAN BULL -23.4
VSBC VitaSpring Biomedical Co. Ltd. $10M -13.8 10.3 15.9 — -100.0 4 LEAN BULL -96.8
LOBEF Lobe Sciences Ltd. $10M -2.7 359.0 181.6 — — 2 LEAN BULL 29.6
PXMD PaxMedica, Inc. Common Stock — -0.0 -7716.2 572.1 — — 2 LEAN BULL 600.0
HEPA Hepion Pharmaceuticals, Inc. — -0.5 -125.6 710.2 — — 3 LEAN BULL 92.1
BTAX Biostax Corp. — -0.0 7.3 5.8 — — 2 LEAN BULL 100.0
VAXX Vaxxinity, Inc. — -0.2 -150.6 2534.7 — — 0 LEAN BULL 23.3
REVB Revelation Biosciences, Inc. — -0.1 -154.8 1317.2 — — 4 LEAN BULL 194.5
ACHFF Arch Biopartners Inc. $40M -20.0 73.5 165.4 — 100.0 2 LEAN BULL -12.6
PRLD Prelude Therapeutics Incorporated $210M -4.9 -57.7 14236.3 -244.1 220.3 5 LEAN BULL 139.5
BRVE Braveheart Bio, Inc. $1.5B — — — — — — LEAN BULL —
SRZN Surrozen, Inc. $190M -0.7 387.2 11.1 1003.5 -8.8 2 LEAN BULL 114.8
MDNAF Medicenna Therapeutics Corp. $20M — — — — — — LEAN BULL —
ABPO Abpro Holdings, Inc. — — — — — — — LEAN BULL —
CYDY CytoDyn Inc. $380M -4.9 57.8 24.6 — 100.0 4 LEAN BULL -16.2
SPRB Spruce Biosciences, Inc. $130M -1.1 -106.0 772.2 — -100.0 4 LEAN BULL -65.7
OCEA Ocean Biomedical, Inc. — -0.0 36.5 0.3 — — 1 LEAN BULL -20.0
PVLA Palvella Therapeutics, Inc. $1.8B -27.4 -46.6 137.5 — — 3 LEAN BULL 82.1
TYRA Tyra Biosciences, Inc. $1.2B -8.9 -45.3 -2390.9 — — 2 LEAN BULL 51.2
PRTA Prothena Corporation plc $420M -10.5 -14.4 -871.5 -1839.9 427.3 5 LEAN BULL -10.3
ENTA Enanta Pharmaceuticals, Inc. $340M -5.0 -70.1 141.5 -135.8 0.7 4 LEAN BULL 15.9
GLSI Greenwich LifeSciences, Inc. $240M -11.0 -951.6 299.9 — — 2 LEAN BULL 74.4
CLNN Clene Inc. $60M -1.1 237.2 132.5 -14915.6 -31.1 2 LEAN BULL -52.4
EHOS Ehouse Global, Inc. — -0.0 161.0 52.5 — — 1 LEAN BULL 0.0
CPMV Mosaic ImmunoEngineering Inc. — -2.0 9.2 7.5 — — 2 LEAN BULL -51.2
DNAG DNAPrint Genomics, Inc. — -0.0 63.1 -156.0 -826.7 -15.2 3 LEAN BULL 100.0
ONCSQ OncoSec Medical Incorporated — -0.0 -410.2 452.1 — — 2 LEAN BULL -90.0
RBSH Rebus Holdings, Inc. — -0.0 -9.7 8.9 — — 2 LEAN BULL 0.0
SRPT Sarepta Therapeutics, Inc. $1.9B -13.0 -9.5 -6.3 -1.2 -20.4 4 NEUTRAL -17.2
ABVC ABVC BioPharma, Inc. $30M -3.6 -82.2 -43.0 — -100.0 2 NEUTRAL -64.4
ANAB AnaptysBio, Inc. $1.5B 7.3 -1146.3 466.0 668.9 92.9 5 NEUTRAL 112.3
STAB Statera Biopharma, Inc. — -0.0 -298.8 2085.4 -769.5 1459.1 3 NEUTRAL -50.0
OBX Obsidian Therapeutics Inc. $10M — — — — — — NEUTRAL —
GBIM GlobeImmune, Inc. — -0.0 -66.2 25.0 -91.5 55.1 4 NEUTRAL 0.0
CNSP CNS Pharmaceuticals, Inc. $10M -0.2 -106.6 748.6 — — 3 NEUTRAL -38.4
SABS SAB Biotherapeutics, Inc. $260M 0.9 -11.3 -48.4 — -100.0 3 NEUTRAL 1.3
NWBO Northwest Biotherapeutics, Inc. $260M -6.7 55.8 -188.7 -1142.6 98.6 3 NEUTRAL -33.7
MLLCF Molecular Partners AG $150M -2.3 -62.1 650.3 — -100.0 2 NEUTRAL 14.6
HESG Health Sciences Group, Inc. — -0.0 69.4 44.6 -19219.1 101.6 3 NEUTRAL 900.0
CTXR Citius Pharmaceuticals, Inc. $10M -0.2 -70.3 -85.4 -593.3 4456.8 3 NEUTRAL -71.9
RGIN Regenicin, Inc. — -0.0 16.9 4.1 — — 4 NEUTRAL 0.0
RCAR RenovaCare, Inc. — -0.0 -436.6 812.3 — — 2 NEUTRAL 9900.0
NMTRQ 9 Meters Biopharma, Inc. — — — — — — — NEUTRAL 900.0
CFRXQ ContraFect Corp. — -0.0 544.7 276.9 — — 1 NEUTRAL -90.0
LYCA Lycia Therapeutics Inc. $1.6B — — — — — — N/A —
CTY City Therapeutics Inc. $200M — — — — — — N/A —
IAM Iambic Therapeutics Inc. $130M — — — — — — N/A —
ATOS Atossa Therapeutics, Inc. $30M -0.6 -89.2 -4213.1 — — 2 NEUTRAL -83.0
LONA LeonaBio, Inc. $20M — — — — — — NEUTRAL —
ORGS Orgenesis Inc. — -0.2 764.3 1083.0 2628.2 -192.0 1 NEUTRAL 66.7
JANX Janux Therapeutics, Inc. $1.0B -10.4 -10.7 516.9 -214.0 7162.0 4 NEUTRAL -30.7
ODTX Odyssey Therapeutics, Inc. $940M — — — — — — NEUTRAL —
DRUG Bright Minds Biosciences Inc. $520M -26.2 -13.7 -105758.3 — — 3 NEUTRAL -11.7
PHMMF Pharma Mar, S.A. $1.6B 21.2 24.9 35.9 -2.0 15.5 7 NEUTRAL 1.7
NMAD NOMAD Power Solutions, Inc. $50M — — — — — — NEUTRAL —
KLDO Kaleido Biosciences, Inc. — -0.0 -591.2 1121.9 -4292.5 13.2 2 NEUTRAL -96.7
CNBX CNBX Pharmaceuticals Inc. — -1.0 17.8 13.3 — 100.0 3 NEUTRAL -57.1
CALC CalciMedica, Inc. — -0.2 -365.7 118.3 — — 4 NEUTRAL -91.3
YARW Yarrow Bioscience Inc $180M — — — — — — NEUTRAL —
ELUT Elutia Inc $40M 0.6 -397.0 -290.2 -315.0 -48.8 6 NEUTRAL -10.6
GSTC GlobeStar Therapeutics Corporation — -0.0 60.9 49.1 — — 4 NEUTRAL 9900.0
YDESW YD Bio Limited Warrants — — — — — — — NEUTRAL -69.4
BPTH Bio-Path Holdings, Inc. — -0.0 49.0 15.2 — -100.0 1 NEUTRAL -99.6
RNXT RenovoRx, Inc. $60M -4.3 -125.2 4391.9 -320.2 198.5 3 NEUTRAL 17.8
USRM U.S. Stem Cell, Inc. — -0.0 20.8 23.4 -2836.8 -59.1 5 NEUTRAL 100.0
ZBIO Zenas BioPharma, Inc. $1.8B -2.9 -199.0 5842.1 -11145.6 -93.3 2 NEUTRAL 14.2
VCRE Vicore Pharma Holding AB $260M — — — — — — NEUTRAL —
ENGNW enGene Holdings Inc. Warrants $10M -5.6 -2.3 134.1 — -100.0 2 NEUTRAL -64.6
PBLA Panbela Therapeutics, Inc. — -0.0 270.3 240.0 — 100.0 3 NEUTRAL 0.0
EVAX Evaxion Biotech A/S $20M -0.5 -109.8 -260.4 — 135.9 6 NEUTRAL -48.4
NXTC NextCure, Inc. $20M -0.5 -195.2 949.7 — — 2 NEUTRAL -37.8
ATXI Avenue Therapeutics, Inc. — -0.5 -120.0 178.4 — -100.0 2 NEUTRAL -43.9
MRPI Mera Pharmaceuticals, Inc. — -10000.0 24.3 18.3 -159.9 4.8 5 NEUTRAL 0.0
MBXBF Microbix Biosystems Inc. $30M -8.6 -16.4 -14.6 -19.9 -27.1 3 LEAN BEAR 24.3
INRLF Valneva SE $640M -2.8 -118.0 -54.8 -89.3 -27.2 1 LEAN BEAR -25.4
POLBF Poolbeg Pharma PLC $70M -8.5 -58.8 -255.9 — — 1 LEAN BEAR 125.4
CLYYF Celyad Oncology S.A. $10M 2.5 -11.7 -979.7 64360.6 -88.7 5 LEAN BEAR 40.0
QPTFF Quest PharmaTech Inc. $10M 1.6 3.9 -1.7 — — 4 LEAN BEAR 125.6
OKUR OnKure Therapeutics, Inc. $100M -0.7 -46.9 1464.5 — — 4 LEAN BEAR -21.7
SNGX Soligenix, Inc. $10M -0.3 -241.7 304.6 — — 4 LEAN BEAR -86.5
ENDV Endonovo Therapeutics, Inc. — -0.2 9.2 4.5 — -100.0 3 LEAN BEAR -50.0
APLMW Apollomics, Inc. $170M -2.6 -233.7 845.7 1188.0 -75.9 3 LEAN BEAR -56.5
ARMP Armata Pharmaceuticals, Inc. $140M -0.7 127.8 -54.7 2953.8 -35.1 2 LEAN BEAR -42.4
EQ Equillium, Inc. $80M -5.2 -59.0 2703.6 — -100.0 3 LEAN BEAR -3.5
LEXX Lexaria Bioscience Corp. $10M -0.6 -150.3 -504.2 — -68.5 4 LEAN BEAR -78.8
KPTI Karyopharm Therapeutics Inc. $10M -0.0 79.0 36.3 -200.5 6.8 2 LEAN BEAR -92.4
ADXN Addex Therapeutics Ltd — -0.4 -150.5 -168.4 -17543.0 -48.1 2 LEAN BEAR -68.8
SRBCF Sirona Biochem Corp. — -0.7 111.4 1025.7 -34808.5 -119.4 2 LEAN BEAR -50.5
NKGN NKGen Biotech, Inc. — -0.0 150.9 — -4511.3 — 3 LEAN BEAR -47.5
REPCF RepliCel Life Sciences Inc. — -9.4 -248.8 -13.9 -80.9 200.0 6 LEAN BEAR 0.0
IMVIF IMV Inc. — -0.2 -503.3 -2870.5 — — 1 LEAN BEAR 1900.0
JUNS Jupiter Neurosciences, Inc. — -0.1 -1888.7 5586.0 -9380.9 — 3 LEAN BEAR -97.7
MCET MultiCell Technologies, Inc. — -0.1 101.2 99.1 -81.8 1532.7 5 LEAN BEAR 900.0
SLGL Sol-Gel Technologies Ltd. $230M -12.4 -35.9 -228.0 36.4 282.9 3 LEAN BEAR 74.8
MMIRF MedMira Inc. $30M -11.4 11.8 21.7 -200.5 45.7 4 LEAN BEAR -20.4
JBIO Jade Biosciences, Inc. $930M -5.4 -47.8 629.9 — — 3 LEAN BEAR 47.4
CGEM Cullinan Therapeutics, Inc. $880M -4.4 -50.3 1635.6 — — 1 LEAN BEAR 91.2
ACRS Aclaris Therapeutics, Inc. $550M -6.6 -59.1 -206.5 -1320.1 -51.0 3 LEAN BEAR 76.3
IFRX InflaRx N.V. $230M -3.0 -38.5 251.5 — -106.2 4 LEAN BEAR 18.6
LADX LadRx Corporation — -0.0 278.9 118.4 — -61.0 1 LEAN BEAR -99.0
LYRA Lyra Therapeutics, Inc. — -0.0 -6595.0 -671.6 -99300.0 -74.1 4 LEAN BEAR -97.6
PARD Poniard Pharmaceuticals, Inc. — -0.0 -210.4 -442.5 — — 3 LEAN BEAR 0.0
ADRX ADARx Pharmaceuticals, Inc. $1.9B — — — — — — LEAN BEAR —
AOBI American Oriental Bioengineering, Inc. — -0.0 -28.2 -16.5 -118.1 -10.2 3 LEAN BEAR 983.3
HSTC HST Global, Inc. $210M -538.5 -2.5 -1.2 -13.7 564.0 5 LEAN BEAR 349900.0
DBVT DBV Technologies S.A. $230M -2.6 -142.6 -2201.5 — -100.0 2 LEAN BEAR -34.3
RNA Atrium Therapeutics, Inc. $140M -2.1 -36.9 455.9 -672.0 235.3 5 LEAN BEAR -82.9
PBIGF Paradigm Biopharmaceuticals Limited $10M -1.6 -456.6 1081.8 -60158.9 53.6 4 LEAN BEAR -96.1
ADAPY Adaptimmune Therapeutics plc $10M -0.1 -1341.1 268.4 -221.8 -54.0 0 LEAN BEAR -55.3
FPMI FluoroPharma Medical, Inc. — -0.0 22.7 39.7 — — 2 LEAN BEAR 100.0
PREDQ Predictive Discovery Limited — — — — — — — LEAN BEAR —
GBLX GB Sciences, Inc. — -0.0 19.5 17.2 -103.2 — 3 LEAN BEAR -75.0
IMMB Immunotech Laboratories, Inc. — — — — — — — LEAN BEAR 100.0
FENC Fennec Pharmaceuticals Inc. $350M -81.5 -18.6 -76.2 11.0 77.8 6 LEAN BEAR 18.1
INBX Inhibrx Biosciences Inc. $1.4B -11.2 -1773.6 55.8 — -100.0 4 LEAN BEAR 67.0
KARD Kardigan, Inc. $1.1B — — — — — — LEAN BEAR —
YDES YD Bio Limited Ordinary Shares $350M — — — — — — LEAN BEAR -64.9
FATE Fate Therapeutics, Inc. $250M -2.0 -60.7 -140.1 -1448.6 -23.4 2 LEAN BEAR 115.1
BDTX Black Diamond Therapeutics, Inc. $110M -2.4 -37.2 -1604.9 — -100.0 1 LEAN BEAR -55.5
NTHI Neonc Technologies Holdings, Inc. $90M — — — — — — LEAN BEAR -66.1
SGMOQ Sangamo Therapeutics, Inc. $50M — — — — — — LEAN BEAR —
ENVB Enveric Biosciences, Inc. $10M -0.1 -170.0 3225.6 — — 4 LEAN BEAR -80.8
PZRXQ PhaseRx, Inc. — -0.0 -228.2 8803.4 — — 2 LEAN BEAR 0.0
NNLX NanoLogix, Inc. — — — — — — — LEAN BEAR -20.0
CLAZF Claritas Pharmaceuticals, Inc. — 0.0 -170.1 15.9 — — 3 LEAN BEAR 0.0
NNBP Nanobac Pharmaceuticals, Incorporated — 0.0 358.0 221.2 -26718.6 -92.2 3 LEAN BEAR 0.0
GWIN Glorywin Entertainment Group, Inc. $360M -26081.4 11.7 5.1 — — 1 LEAN BEAR 229.5
FGHQF Frontage Holdings Corporation $360M 36.5 3.1 3.0 4.6 9.8 7 LEAN BEAR 16.8
KNTPF Kintor Pharmaceutical Limited $120M -2.9 -116.6 -74.4 -145.6 2237.9 3 LEAN BEAR -10.2
LVCLF Algorae Pharmaceuticals Limited $20M -5.4 -47.4 -24288.6 — -100.0 3 LEAN BEAR 51.6
BCLI Brainstorm Cell Therapeutics Inc. $10M -0.8 119.2 76.7 — -100.0 1 LEAN BEAR 12.7
FORU ForU Holdings, Inc. — -0.0 759.2 -476.4 — -100.0 2 LEAN BEAR 100.0
CHNXF ChitogenX Inc. — -0.2 23.2 36.2 — — 2 LEAN BEAR 586.4
HLSQ Tessera Defense and Homeland Security Inc — — — — — — — LEAN BEAR —
CMND Clearmind Medicine Inc. — -0.1 -104.0 593.4 — — 2 LEAN BEAR -99.8
VINC Vincerx Pharma, Inc. — -0.0 -3136.4 910.2 — -18.7 5 LEAN BEAR -53.1
NURPF Neuren Pharmaceuticals Limited $1.8B 118.1 6.2 22.4 14.6 -68.5 5 LEAN BEAR 20.8
CUBT Curative Biotechnology, Inc. — -1.9 31.0 15.3 — — 4 LEAN BEAR 8.5
KZIA Kazia Therapeutics Ltd ADR $10M -1.1 -104.5 62.7 — -99.2 4 LEAN BEAR 17.1
LIANY LianMedical — 1.1 74.7 -612.1 — — 6 LEAN BEAR -28.6
TSHA Taysha Gene Therapies, Inc. $1.3B -10.1 -47.1 961.0 — -32.3 3 BEARISH -10.5
ARVN Arvinas, Inc. $470M 39.1 1.6 -519.3 67.8 -15.0 4 BEARISH -19.1
CAMP CAMP4 Therapeutics Corporation $210M -1.6 -545.9 48.4 -1884.8 40.2 2 BEARISH -1.9
PBMWW Psyence Biomedical Ltd. Warrant — — — — — — — BEARISH -58.1
CARM Carisma Therapeutics, Inc. — 0.0 -134.1 -376.4 98.8 159.7 3 BEARISH -99.2
TRVN Trevena, Inc. — -0.0 344.3 -3198.4 -1745.2 -82.9 3 BEARISH -7.5
PKTX ProtoKinetix, Incorporated — -1.0 -117.2 -115.0 — — 2 BEARISH -95.4
INNMF Amplia Therapeutics Limited $30M -4.7 -24.9 -86.9 — -100.0 2 BEARISH -35.3
IMUC EOM Pharmaceuticals Holdings, Inc. $10M -4.9 64.4 131.0 — — 4 BEARISH -42.8
AAGH America Great Health — 2.0 -12.2 22.4 -635.8 -5.1 4 BEARISH 33.3
BXRXQ Baudax Bio, Inc. — — — — — — — BEARISH 900.0
SNBIF SanBio Company Limited $1.3B -19.5 -55.8 -2935.2 — — 3 BEARISH 0.0
OVID Ovid Therapeutics Inc. $420M -4.7 -26.0 -43.7 -2047.6 -76.2 3 BEARISH 38.6
RZLT Rezolute, Inc. $370M -5.4 -59.0 1060.6 — — 2 BEARISH -55.3
MDWD MediWound Ltd. $150M -7.7 -72.4 -255.1 -239.1 -40.3 2 BEARISH -31.9
CSBR Champions Oncology, Inc. $70M -60.8 -30.7 -7.8 -2.8 6.7 3 BEARISH -29.9
MRKR Marker Therapeutics, Inc. $20M -2.0 -76.9 -1014.3 — -77.1 2 BEARISH -7.6
DTCFF Defence Therapeutics Inc. $20M -3.8 -237.8 -86.8 — — 4 BEARISH -53.1
XCUR Exicure, Inc. $10M -0.8 -168.4 779.8 — — 2 BEARISH -78.0
VRCI Verde Science, Inc. — -0.0 72.3 23.0 — — 5 BEARISH 100.0
HLUN HEALTHeUNIVERSE, Inc. — — — — — — — BEARISH 900.0
SNNAQ Sienna Biopharmaceuticals, Inc. — -0.0 -140.9 -331.4 — — 2 BEARISH 0.0
IBOGF Universal Ibogaine Inc. — -0.5 -94.8 5.5 -9.4 208.2 4 BEARISH -98.4
NTII Neurobiological Technologies, Inc. — 0.0 48.7 441.6 89.7 99.7 4 BEARISH 0.0
GLSHQ Gelesis Holdings, Inc. — -0.0 391.0 -233.6 -693.9 -45.8 3 BEARISH 0.0
CMRA Comera Life Sciences Holdings, Inc. — -0.0 235.6 124.2 -1580.0 81.8 4 BEARISH 0.0
HAVLF HAVN Life Sciences Inc. — -0.0 -275.3 -163.4 5734.1 876.8 3 BEARISH 0.0
PSYBF PsyBio Therapeutics Corp — -0.0 344.6 135.0 — — 2 BEARISH -90.0
TLOG TetraLogic Pharmaceuticals Corporation — -0.0 382.3 479.8 — — 1 BEARISH 0.0
MRZM Marizyme, Inc. — -0.0 117.5 -190.1 — -69.0 3 BEARISH 0.0
TRVI Trevi Therapeutics, Inc. $1.8B -39.6 -19.7 -1451.7 — — 3 BEARISH 27.0
QURE uniQure N.V. $1.6B -5.9 -157.6 37.9 -1387.8 30.2 4 BEARISH -60.2
BPMUF Basilea Pharmaceutica AG $960M 16.9 39.5 75.9 23.5 4.5 7 BEARISH 27.1
DNA Ginkgo Bioworks Holdings, Inc. $670M -2.3 -56.3 -44.0 -231.7 -51.5 2 BEARISH -16.9
INKT MiNK Therapeutics, Inc. $50M -4.4 57.9 42.8 — — 4 BEARISH -29.0
CURX Curanex Pharmaceuticals Inc Common Stock $10M -0.6 -218.7 -392.2 — — 1 BEARISH -64.0
SYGGF Synairgen plc — -0.2 -71.9 -381.4 — — 1 BEARISH -50.0
RAPP Rapport Therapeutics, Inc. Common Stock $1.2B -9.1 -40.0 3981.5 — — 4 BEARISH 6.2
ATGGF Actinogen Medical Limited $140M -8.5 -77.5 -235.8 — -100.0 1 BEARISH 17.2
NRXP NRx Pharmaceuticals, Inc. $110M -3.6 131.2 61.3 -1500.5 — 5 BEARISH -14.6
SQZB SQZ Biotechnologies Company — -0.0 -203.4 -410.2 — -44.6 0 BEARISH 4.3
MEOBF Mesoblast Limited $2.0B -29.4 -9.9 -14.4 -23.4 613.8 5 BEARISH -20.0
CEROW CERo Therapeutics Holdings, Inc. — -0.0 101.5 60.5 — -100.0 1 BEARISH -75.2
BCRX BioCryst Pharmaceuticals, Inc. $1.9B -5.6 87.8 62.3 35.9 68.7 5 BEARISH 12.5
APMD Apnimed, Inc. $790M — — — — — — BEARISH —
STTK Shattuck Labs, Inc. $550M -11.4 -39.2 -29.3 — -66.6 4 BEARISH 200.5
BNTC Benitec Biopharma Inc. $300M -8.9 -33.2 1840.8 — — 3 BEARISH -35.5
ELDN Eledon Pharmaceuticals, Inc. $190M -2.4 -110.7 411.1 — — 2 BEARISH -30.8
CHRS Coherus Oncology, Inc. $160M -1.0 -145.4 1854.0 -144.2 -64.3 2 BEARISH -35.1
FHTX Foghorn Therapeutics Inc. $120M -2.0 81.9 26.3 -44.7 52.0 4 BEARISH -49.6
MAIA MAIA Biotechnology, Inc. $70M -1.9 -218.7 330.4 — — 3 BEARISH -18.2
AURX Nuo Therapeutics, Inc. $60M -31.1 170.6 280.3 -15.7 166.6 3 BEARISH -47.8
RNTX Rein Therapeutics Inc. $50M -0.4 -753.6 53.9 — — 3 BEARISH -51.1
ELTX Elicio Therapeutics, Inc. $40M -0.8 -774.6 2147.3 — — 4 BEARISH -81.1
JSPR Jasper Therapeutics, Inc. $20M -0.3 -255.0 773.9 — — 2 BEARISH -78.1
NCNA NuCana plc $10M -0.3 -70.7 -739.9 — — 4 BEARISH -74.2
GDTC CytoMed Therapeutics Limited $10M -2.5 -66.1 -87.8 -1125.6 -11.3 0 BEARISH -62.8
RLFTY MindMaze Therapeutics Holding S.A. — -4.6 -36.8 -30.3 -1182.3 -95.8 2 BEARISH -95.4
JAGX Jaguar Health, Inc. — -0.0 -501.9 -118.9 -1035.3 135.5 4 BEARISH -99.8
HTDS Hard to Treat Diseases Inc. — — — — — — — BEARISH 0.0
BIXT Bioxytran, Inc. — -0.7 92.2 68.7 — — 4 BEARISH -56.8
ITMC Itoco Inc. — -0.0 303.4 96.7 — — 2 BEARISH 0.0
PPTDF PeptiDream Inc. $870M -38.0 -7.1 -9.6 -25.7 47.8 4 BEARISH -38.7
TRDA Entrada Therapeutics, Inc. $170M -1.1 -54.1 -236.6 -4762.0 -94.1 1 BEARISH -35.4
ERNA Ernexa Therapeutics Inc. — -0.1 -320.7 626.9 — -100.0 5 BEARISH -93.6
MRES Institute of Biomedical Research Corp. — -2.3 301783.0 -6062.7 — — 1 BEARISH -81.2
CSPHF CStone Pharmaceuticals $1.4B -14.4 -51.4 -340.2 -123.0 135.6 5 BEARISH -15.4
DRTSW Alpha Tau Medical Ltd. $1.2B -13.0 -141.7 -17.1 — — 3 BEARISH 807.7
RLYB Rallybio Corporation $90M 3.4 34.5 -1198.7 — -35.6 6 BEARISH 2511.5
LSTA Lisata Therapeutics, Inc. $10M -0.6 -99.9 590.1 — -90.7 2 BEARISH -56.6
AEON AEON Biopharma, Inc. $10M -0.1 350.0 98.0 — — 2 BEARISH -73.5
PROT Proteonomix, Inc. — -0.0 77.5 -1239.4 — -63.1 4 BEARISH 0.0
NBIO Nascent Biotech, Inc. — -0.0 230.6 328.8 — — 5 BEARISH -75.0
SIGY Sigyn Therapeutics, Inc. — -0.0 61.7 32.8 — -100.0 1 BEARISH -98.5
ONCO Onconetix, Inc. — -0.1 -105.2 -83.7 -16748.3 -51.3 3 BEARISH -86.8
RNUGF ReNeuron Group plc — -0.0 -106.8 210.1 -1809.6 -68.2 1 BEARISH 0.0
BRAXF Braxia Scientific Corp. — -0.1 -254.6 -2393.3 -184.2 27.6 3 BEARISH -99.9
PFND Pathfinder Cell Therapy, Inc. — -0.0 22.4 46.3 — — 2 BEARISH 0.0
CDXI Cardax, Inc. — -0.0 81.1 38.5 -1740.8 -27.3 2 BEARISH 0.0
ADYX Adynxx, Inc. — -0.0 1148.3 259.7 — -95.1 2 BEARISH 0.0
PANC Panacos Pharmaceuticals, Inc. — -0.0 -168.8 -792.8 -33966.7 -45.9 1 BEARISH 0.0
SYVC Synovics Pharmaceuticals, Inc. — — — — — — — BEARISH 0.0
WHWK Whitehawk Therapeutics Inc $180M -3.0 -45.0 963.4 — -100.0 1 BEARISH 38.2
ATRA Atara Biotherapeutics, Inc. $90M -7.1 46.3 30.3 -767.3 -96.7 2 BEARISH -42.7
HNSBF Hansa Biopharma AB (publ) $330M -4.6 159.8 1182.7 -541.7 -3.7 2 BEARISH -28.2
VICP Vicapsys Life Sciences, Inc. $10M -20.5 31.3 17.6 — — 5 BEARISH -73.3
VOGX Vogenx Inc. $260M — — — — — — BEARISH —
CASIF CASI Pharmaceuticals, Inc. — — — — — — — BEARISH —
IDRSF Idorsia Ltd $1.4B -3.5 27.1 -344.5 -203.1 -8.1 1 BEARISH 19.6
VBIZF Viva Biotech Holdings $400M 13.1 4.5 4.2 8.0 2.9 7 BEARISH -35.1
RCKT Rocket Pharmaceuticals, Inc. $250M -15.5 -4.8 -137.8 — — 3 BEARISH -36.4
CRVS Corvus Pharmaceuticals, Inc. $890M -16.5 -35.4 -415.6 — — 4 BEARISH 43.4
SVRA Savara Inc. $870M -8.4 -105.5 -15438.9 — — 2 BEARISH 11.5
IMRX Immuneering Corporation $240M -3.7 -52.1 -112.8 — — 4 BEARISH -36.6
PMN ProMIS Neurosciences, Inc. $70M -0.6 -172.3 844.3 — — 2 BEARISH -10.3
IMTX Immatics N.V. $1.1B -4.1 -47.8 -858.3 -683.4 -68.0 2 BEARISH -28.7
KURA Kura Oncology, Inc. $850M -2.9 -167.7 56.3 -327.3 -7.3 1 BEARISH 2.1
ATTO Attovia Therapeutics, Inc. $630M -15.3 -294.4 -1137.2 -4597.1 -50.5 4 BEARISH 272.2
OCS Oculis Holding AG $490M -4.7 -44.0 -31.0 — -6.9 3 BEARISH -63.1
DYAI Dyadic International, Inc. $20M -1.9 522.6 1288.0 -221.0 1.5 3 BEARISH -65.5
DVHGF Devonian Health Group, Inc. $20M — -76.1 -75.1 -1098.1 -91.5 1 BEARISH 37.7
ALLR Allarity Therapeutics, Inc. $10M -1.2 -157.1 -96.5 — — 2 BEARISH -33.8
SCPS Scopus BioPharma Inc. — -0.0 132.3 53.6 — — 2 BEARISH 33.3
BIORQ Biora Therapeutics, Inc. — — — — — — — BEARISH —
BITRF Biotron Limited — -3.6 -87.5 -87.8 -113.4 -71.0 0 BEARISH -90.7
THER Theralink Technologies, Inc. — -0.0 6.0 -69.7 5363.6 32.8 2 BEARISH 0.0
AURA Aura Biosciences, Inc. $650M -3.5 -53.5 -1360.0 — — 4 BEARISH 7.5
TTRX Turn Therapeutics Inc. $310M -36.1 -952.4 115.0 — — 2 BEARISH 105.1
ARCT Arcturus Therapeutics Holdings Inc. $280M -3.4 -46.3 -2501.0 -803.8 -79.1 1 BEARISH 0.1
SPHRY Starpharma Holdings Limited $220M -26.0 -46.5 -441.4 -725.1 186.8 4 BEARISH 73.3
BETRF BetterLife Pharma Inc. $110M -10.0 34.9 21.6 — — 4 BEARISH 243.4
NTRB Nutriband Inc. $70M -10.6 -100.7 -264.9 -201.3 -37.3 3 BEARISH -16.8
HRGN Harvard Apparatus Regenerative Technology Inc. $30M -4.9 239.0 256.6 -409.4 — 2 BEARISH —
PVCT Provectus Biopharmaceuticals, Inc. $20M -4.3 78.1 83.4 — -100.0 5 BEARISH -33.9
APUS Apimeds Pharmaceuticals US, Inc — -0.1 -100.1 -12.6 — — 2 BEARISH -85.1
ERNAW Ernexa Therapeutics Inc. Warrants — — — — — — — BEARISH —
RNAZ TransCode Therapeutics, Inc. — -0.0 -59.2 -21.0 — — 1 BEARISH -87.5
VRPX Virpax Pharmaceuticals, Inc. — -0.0 2.6 0.4 — — 1 BEARISH -96.2
VRAX Virax Biolabs Group Limited — -0.0 -110.9 -481.7 -40439.1 121.6 4 BEARISH 103.4
SCNI Scinai Immunotherapeutics Ltd. — -0.0 -19.2 -53.3 -435.4 162.7 2 BEARISH -63.6
GHRS GH Research PLC $1.2B -20.0 -18.8 2015.5 — — 2 BEARISH 43.5
ABUS Arbutus Biopharma Corp $830M 5.4 89.6 86.7 -507.2 1078.8 4 BEARISH -1.6
QTTB Q32 Bio Inc. $260M 3.1 72.1 435.2 — — 5 BEARISH 193.3
HOPHF Hemogenyx Pharmaceuticals Plc $20M -3.7 -628.5 -474.6 — — 4 BEARISH 0.0
ANL Adlai Nortye Ltd. $560M -5.5 -22.4 -317.5 -36.3 223.4 4 BEARISH 549.1
ARTV Artiva Biotherapeutics, Inc. $300M -1.3 -36.6 -954.6 — — 3 BEARISH -21.1
PLX Protalix BioTherapeutics, Inc. $210M 10.5 31.2 47.1 19.0 30.1 5 BEARISH 7.2
FBIOP Fortress Biotech, Inc. $130M 0.6 107.5 -87.8 -2.5 15.5 6 BEARISH 131.0
ALZN Alzamend Neuro Inc $10M -0.5 -163.2 401.5 — — 1 BEARISH -54.6
AFFY Affymax, Inc. — -0.0 98.1 -302.0 17164.3 -99.9 5 BEARISH -11.1
XBIO Xenetic Biosciences, Inc. — -1.5 -47.0 523.4 -140.7 33.3 4 BEARISH -54.6
PLYX Polaryx Therapeutics, Inc. Common Stock $90M -15.3 -35.9 437.3 — — 2 BEARISH —
SYRS Syros Pharmaceuticals, Inc. — -0.0 -777.0 960.6 — -90.5 0 BEARISH 0.0
MLYS Mineralys Therapeutics, Inc. $1.8B -4.9 -80.9 2274.6 — — 2 BEARISH -47.0
GENB Generate Biomedicines, Inc. $1.6B -7.9 -28.2 -175.0 -1065.2 — 1 BEARISH —
CMPS COMPASS Pathways plc $1.6B -2.1 -319.1 48.8 — — 2 BEARISH 88.1
NKTR Nektar Therapeutics $1.1B -5.7 -35.8 -29.2 -401.0 -27.2 3 BEARISH -36.8
AVBP ArriVent BioPharma, Inc. $1.0B -4.1 -53.1 2345.1 — — 3 BEARISH -17.2
ALMS Alumis Inc. $880M -1.8 -93.6 2645.2 -8557.2 -63.1 2 BEARISH 47.2
SANA Sana Biotechnology, Inc. $700M -3.2 -152.9 -242.3 — — 3 BEARISH -55.8
FULC Fulcrum Therapeutics, Inc. $280M -3.1 -32.4 2389.1 — — 4 BEARISH -59.9
IPSC Century Therapeutics, Inc. $260M -1.4 -49.7 -60.0 — -100.0 2 BEARISH 151.2
TARA Protara Therapeutics, Inc. $140M -1.8 -45.8 -41.3 — — 2 BEARISH -51.6
OTLK Outlook Therapeutics, Inc. $130M -0.5 256.9 1372.0 -225766.7 -169.4 3 BEARISH -61.9
VERU Veru Inc. $40M -3.8 -62.3 -211.2 — -100.0 3 BEARISH -40.0
SEOVF Sernova Corp. $30M -3.7 57.0 76.3 — — 3 BEARISH -35.6
SNANF Sona Nanotech Inc. $20M -12.9 526.4 252.2 — — 1 BEARISH -58.7
AKTX Akari Therapeutics, Plc $20M -0.0 -139.9 -175.8 — — 3 BEARISH -71.0
LTRN Lantern Pharma Inc. $10M -0.4 -400.9 115.9 — — 2 BEARISH -84.3
HMTXF Hemostemix Inc. $10M -2.0 69.9 190.1 — — 1 BEARISH -44.5
ADIL Adial Pharmaceuticals, Inc. $10M -0.2 -2011.6 159.6 — — 3 BEARISH -58.8
ANEB Anebulo Pharmaceuticals, Inc. $10M -1.7 -69.7 650.7 — — 1 BEARISH -90.5
PLRZ Polyrizon Ltd. $10M -2.0 -21.4 -68.2 — — 0 BEARISH 39.6
SNTI Senti Biosciences, Inc. $10M -0.1 -466.5 -430.9 -75000.0 — 2 BEARISH -91.0
AMBS Amarantus BioScience Holdings, Inc. — -0.0 7.3 3.8 -4080.5 — 3 BEARISH -66.7
ANTH Anthera Pharmaceuticals, Inc. — -0.0 -251.4 1107.5 — — 1 BEARISH 0.0
ATRX Adhera Therapeutics Inc — -0.0 18.6 6.5 — — 1 BEARISH 0.0
SLXN Silexion Therapeutics Ltd. — -0.0 -17022.0 -931.4 — — 3 BEARISH -95.0
LIPO Lipella Pharmaceuticals Inc. — -0.0 -361.8 4105.8 — -64.1 1 BEARISH -99.9
EVGN Evogene Ltd. — -0.4 265.3 101.3 -509.5 -80.4 3 BEARISH -69.6
AMPE Ampio Pharmaceuticals, Inc. — -0.0 -114.0 1652.6 -838.4 — 4 BEARISH 5806.4
ORIC ORIC Pharmaceuticals, Inc. $1.4B -6.7 -39.8 -102.9 — — 3 BEARISH -31.3
IMRN Immuron Limited $10M -2.9 -40.2 -187.8 -54.4 -29.7 5 BEARISH -56.7
BCTXZ BriaCell Therapeutics Corp. Warrant — -0.3 -168.1 -2016.9 — — 1 BEARISH -68.2
ANRO Alto Neuroscience, Inc. $860M -9.3 -49.2 -201.4 — — 3 BEARISH 110.7
DSGN Design Therapeutics, Inc. $640M -9.1 -34.1 1787.8 — — 1 BEARISH 85.5
BRIBF Brii Biosciences Limited $90M -3.3 -10.3 -62.6 — 22.5 4 BEARISH -46.0
ELOX Eloxx Pharmaceuticals, Inc. $40M -8.5 -107.5 81.5 — — 4 BEARISH 13339900.4
AUTL Autolus Therapeutics plc $410M -1.5 -132.9 451.5 -85.6 292.0 3 BEARISH 1.3
BVAXF BioVaxys Technology Corp. — -0.9 310.6 48.4 — — 1 BEARISH -45.4
AVLN Avalyn Pharma Inc. Common Stock $1.1B — — — — — — BEARISH —
BCAX Bicara Therapeutics Inc. Common Stock $1.1B -5.6 -41.0 583.9 — — 2 BEARISH 2.0
MNKD MannKind Corporation $1.0B -23.4 71.4 4.0 -17.4 30.5 2 BEARISH -38.0
GLUE Monte Rosa Therapeutics, Inc. $920M -4.8 -42.7 149.9 -483.9 -83.9 3 BEARISH -4.3
WVE Wave Life Sciences Ltd. $630M -3.2 -80.0 -1243.7 -470.5 -35.1 4 BEARISH -51.6
LRMR Larimar Therapeutics, Inc. $240M -1.2 -139.6 590.9 — — 2 BEARISH -43.2
ALXO ALX Oncology Holdings Inc. $160M -1.0 -80.6 -851.1 — — 4 BEARISH -37.1
HUMA Humacyte, Inc. $120M -0.9 -547.9 -500.7 -9064.5 -73.6 3 BEARISH -73.9
IMUX Immunic, Inc. $100M -1.6 -138.2 345.6 — — 5 BEARISH -0.9
ADAG Adagene Inc. $90M -5.6 -28.6 111.8 -1011.1 8927.0 5 BEARISH 45.8
RECEF Recce Pharmaceuticals Ltd $70M -6.0 151.4 200.5 — -100.0 2 BEARISH -56.0
TELO Telomir Pharmaceuticals, Inc. Common Stock $70M -0.7 -213.1 3515.1 — — 4 BEARISH -32.0
TENX Tenax Therapeutics, Inc. $50M -1.2 -59.8 1235.8 — — 1 BEARISH -76.7
CVM CEL-SCI Corporation $30M -0.6 -252.5 -142.9 — -100.0 4 BEARISH -82.9
ARTL Artelo Biosciences, Inc. $10M -0.0 -705.7 -1031.2 — — 5 BEARISH -92.8
FNAM Evolutionary Genomics, Inc. — -0.0 62.2 -99.6 — — 2 BEARISH 0.0
WINT Windtree Therapeutics, Inc. — -0.0 1111.0 -2375.5 — — 3 BEARISH -99.6
SYBE SYBLEU Inc — -3.1 71.5 -202.2 -685.7 — 2 BEARISH 0.0
RGRX RegeneRx Biopharmaceuticals, Inc. — -0.0 53.5 45.8 -2006.3 -0.0 3 BEARISH 450.0
BICTF Biocure Technology Inc. — -0.1 -889.9 60.0 — — 1 BEARISH 0.0
INVA Innoviva, Inc. $1.5B 4.3 36.7 15.0 -69.8 19.8 7 BEARISH 18.2
ACHV Achieve Life Sciences, Inc. $670M -4.4 -845.0 24.6 — — 2 BEARISH 38.6
EIKN Eikon Therapeutics, Inc. Common Stock $390M — — — — — — BEARISH —
TECX Tectonic Therapeutic, Inc. $390M -4.5 -33.8 -6371.3 — — 1 BEARISH 18.6
CLVLF Clinuvel Pharmaceuticals Limited $250M 10.6 13.2 126.7 41.1 -1.1 6 BEARISH -32.0
RNAC Cartesian Therapeutics, Inc. $190M -1.1 241.0 37.3 — 44.0 2 BEARISH -29.5
NAGE Niagen Bioscience Inc $190M 12.9 21.8 44.7 3.2 11.0 6 BEARISH -67.0
VRXA Veraxa Biotech Holding AG $140M — — — — — — BEARISH —
TNXP Tonix Pharmaceuticals Holding Corp. $90M -0.4 -81.8 -276.2 -299.4 196.0 3 BEARISH -72.3
GNLX Genelux Corporation $90M -2.2 -168.9 20537.7 — — 2 BEARISH -73.8
CNXU Conexeu Sciences Inc. $90M — — — — — — BEARISH —
INO Inovio Pharmaceuticals, Inc. $60M -0.8 -409.9 257.7 — -100.0 1 BEARISH -61.8
ONCY Oncolytics Biotech Inc. $50M -1.9 90135.4 285.1 — — 1 BEARISH -61.5
NDTP NDT Pharmaceuticals Inc. $50M -39.2 -3.8 -1.5 -458.3 — 4 BEARISH -83.3
CLCS Cell Source, Inc. $40M -4.6 27.7 34.5 — — 4 BEARISH 24.0
RVXCF Resverlogix Corp. $20M -1.6 11.5 25.3 — — 4 BEARISH -30.1
NEUP Neuphoria Therapeutics Inc. $20M -0.5 -0.2 -0.2 -417.7 -91.9 4 BEARISH -45.7
CNTX Context Therapeutics Inc. $20M -0.5 -76.1 841.7 — — 2 BEARISH -81.4
LPCN Lipocine Inc. $10M -0.8 -60.9 662.3 -1379.6 -62.7 2 BEARISH -49.7
ICU SeaStar Medical Holding Corporation $10M -0.6 -356.9 415.0 -606.5 123.6 4 BEARISH -59.0
PHIO Phio Pharmaceuticals Corp. $10M -0.6 -113.7 2701.6 — — 2 BEARISH -57.1
CDT CDT Equity Inc. — -0.0 13.1 5.4 9.1 — 7 BEARISH -97.3
BRTX BioRestorative Therapies, Inc. — -0.1 -241.1 2112.9 -9298.3 -8.5 3 BEARISH -95.7
BBLG Bone Biologics Corporation — -0.2 -47.5 1744.6 — — 2 BEARISH -83.6
AFMDQ Affimed N.V. — — — — — — — BEARISH —
SXTP 60 Degrees Pharmaceuticals, Inc. — -0.1 -321.8 -390.2 -1089.2 68.0 3 BEARISH -50.5
SPRC SciSparc Ltd. — -0.0 -519.9 -161.9 -1891.2 -26.8 5 BEARISH -78.9
MTNB Matinas BioPharma Holdings, Inc. — -0.1 -154.3 -504.1 — — 4 BEARISH -92.4
BLEG Branded Legacy, Inc. — -0.0 2011.7 147.0 — -29.4 2 BEARISH -99.5
GRI GRI Bio, Inc. — -0.0 -142.0 1227.5 — — 5 BEARISH -97.2
VCNX Vaccinex, Inc. — -0.4 776.6 414.6 -1584.0 226.6 3 BEARISH -20.1
LNAI Lunai Bioworks Inc. — -0.3 -21.6 30.2 — — 2 BEARISH -97.1
DRMA Dermata Therapeutics, Inc. — -0.2 -183.9 734.5 — — 2 BEARISH -80.8
VIVS VivoSim Labs, Inc. — -0.0 -343.1 241.9 -7433.3 202.7 2 BEARISH -93.5
LITS Lite Strategy, Inc. $40M -0.1 -170.9 -28.2 — — 2 BEARISH -40.2
DRTS Alpha Tau Medical Ltd $1.2B -13.0 -141.7 -17.1 — — 3 BEARISH 219.4
SLDB Solid Biosciences Inc. $630M -3.2 -65.5 -1012.6 — — 3 BEARISH 10.1
ORMP Oramed Pharmaceuticals Inc. $170M 1.0 74.1 -4.3 — -100.0 4 BEARISH 74.1
AMGXF AnGes, Inc. $140M -3.0 -160.6 -111.8 -531.3 -16.1 4 BEARISH 0.0
ANTX AN2 Therapeutics, Inc. $130M -3.5 -50.1 1243.3 — — 2 BEARISH 229.9
BBIXF Bonus BioGroup Ltd. $50M -17.4 3245.0 2543.1 — — 2 BEARISH 13233.3
INTI Inhibitor Therapeutics, Inc. $10M -3.2 358.8 88.0 — — 1 BEARISH 59.8
RMTG Regenerative Medical Technology Group Inc. — -0.1 9.6 -3.3 -72.2 — 3 BEARISH —
MYMX Mymetics Corporation — -0.0 16.6 357.9 -3012.0 -62.8 2 BEARISH 0.0
NWPHF Newron Pharmaceuticals S.p.A. $410M -6.7 83.9 -32.1 -513.4 — 1 BEARISH —
VRXAW Veraxa Biotech AG — — — — — — — BEARISH —
SRNE Sorrento Therapeutics, Inc. — -0.0 1502.8 468.4 -633.7 16.9 2 BEARISH -96.7
OLMA Olema Pharmaceuticals, Inc. $560M -3.3 -52.7 585.3 — — 2 BEARISH -12.3
CBIO Crescent Biopharma, Inc. $480M -1.8 -107.7 1928.6 — — 5 BEARISH 4.6
BLSM BlossomHill Therapeutics, Inc. $430M — — — — — — BEARISH —
GOSS Gossamer Bio, Inc. $60M -0.2 178.7 117.2 182.9 32.4 3 BEARISH -95.1
IBO Impact BioMedical Inc. $30M -3.0 10.8 -30.4 -23300.0 — 5 BEARISH -50.1
AIM AIM ImmunoTech Inc. $10M -0.0 -2382.3 -513.5 -14569.2 -21.5 5 BEARISH -93.5
LGVN Longeveron Inc. — -0.2 -203.6 -2062.6 -2116.0 -42.7 4 BEARISH -81.2
BTAIQ BioXcel Therapeutics, Inc. — — — — — — — BEARISH —
SILO Silo Pharma, Inc. — -0.2 -91.2 645.1 — -25.0 3 BEARISH 116.9
AAPG Ascentage Pharma Group International $1.4B -6.1 -236.8 -144.8 -270.2 170.9 3 BEARISH -58.7
OMER Omeros Corporation $1.2B 9.1 -89.2 71.8 46.4 — 5 BEARISH 131.7
ASCLF Ascletis Pharma Inc. $770M -7.8 -28.4 -7144.0 — -60.6 2 BEARISH -40.0
NVCT Nuvectis Pharma, Inc. $650M -14.0 -214.6 174.4 — — 1 BEARISH 197.4
FDMT 4D Molecular Therapeutics, Inc. $600M -4.3 -43.3 -182.0 -1929.0 278712.1 4 BEARISH 5.5
PHAT Phathom Pharmaceuticals, Inc. $460M -4.7 26.4 8.9 -23.7 110.2 4 BEARISH -55.7
EPRX Eupraxia Pharmaceuticals Inc. $450M -6.9 -68.6 8742.2 — — 3 BEARISH 29.4
AGEN Agenus Inc. $290M 2.4 -33.2 -20.4 -1.6 30.5 6 BEARISH 60.6
GALT Galectin Therapeutics Inc. $210M -8.0 21.9 99.4 — — 2 BEARISH -35.4
CGEN Compugen Ltd. $180M 5.2 49.6 -90.2 -269.3 886.7 5 BEARISH 9.4
SEER Seer, Inc. $110M -1.6 -26.4 -58.8 -544.8 -13.3 3 BEARISH -15.2
VANI Vivani Medical, Inc. $100M -3.3 -220.4 -127.1 — — 4 BEARISH -29.6
COYA Coya Therapeutics, Inc. $90M -3.9 -60.5 -18820.6 -2723.4 1793.8 4 BEARISH -34.6
MNOV MediciNova, Inc. $70M -6.5 -25.6 -78.2 -504.8 583.9 3 BEARISH 14.6
PMVP PMV Pharmaceuticals, Inc. $70M -0.9 -70.9 815.8 — — 2 BEARISH -19.9
OSTX OS Therapies Incorporated $60M -1.1 1924.5 268.9 — — 1 BEARISH -34.4
HRTX Heron Therapeutics, Inc. $60M -1.6 334.6 -7.6 -14.6 1.0 3 BEARISH -74.9
SPRO Spero Therapeutics, Inc. $60M 7.9 19.2 -128.5 — -7.0 7 BEARISH -48.4
XLO Xilio Therapeutics, Inc. $50M -4.9 -55.0 43.1 -34.1 327.3 6 BEARISH 913.9
ALPS Alps Group Inc $50M — — — — — — BEARISH —
MREO Mereo BioPharma Group plc $40M -1.6 -67.8 6194.3 — -100.0 2 BEARISH -85.4
CRVO CervoMed Inc. $30M -0.7 -107.6 1244.8 — — 2 BEARISH -68.6
COCP Cocrystal Pharma, Inc. $20M -1.2 -311.7 -3697.6 -3013.3 — 2 BEARISH -16.9
PHYOF IXICO plc $10M -6.0 -15.8 -23.6 -28.5 13.2 2 BEARISH 0.0
OTLC Oncotelic Therapeutics, Inc. $10M 0.0 181.4 -1.4 155.3 — 5 BEARISH -79.2
GLWLF Glow Lifetech Corp. $10M -50.0 -11.1 -21.1 -26.6 59.2 5 BEARISH -16.1
PASG Passage Bio, Inc. $10M -0.3 -169.1 159.0 — — 3 BEARISH -53.1
KPRX Kiora Pharmaceuticals, Inc. $10M -0.9 -56.4 -2884.1 — — 2 BEARISH -10.2
ADTX Aditxt, Inc. — -0.0 622.6 49.4 -131159.8 -74.1 1 BEARISH -100.0
EVLO Evelo Biosciences, Inc. — -0.0 948.0 605.0 — — 2 BEARISH -80.0
ISCO International Stem Cell Corporation — -2.4 30.4 -10.8 -2.7 3.4 6 BEARISH 2.4
ELAB PMGC Holdings Inc. — -0.0 -73.0 -66.6 -225.1 408.6 3 BEARISH -100.0
YECO EV Biologics, Inc. — -0.0 16.2 18.1 18.6 264.7 5 BEARISH -99.9
HMGN Hemagen Diagnostics, Inc. — -0.0 29.1 -24.6 -18.6 -21.4 2 BEARISH 100.0
CHMMF Chimeric Therapeutics Limited — -0.0 655.2 80.8 — -100.0 2 BEARISH 0.0
CVKD Cadrenal Therapeutics, Inc. Common Stock — -0.2 -275.2 -540.4 — — 3 BEARISH -93.6
AGNPF Grey Matters Health Inc. — — -140.9 -64.7 — — 3 BEARISH -55.6
MAJI Nextel Medical Corp. — 0.6 -2.6 42.9 — — 1 BEARISH —
LIMNW Liminatus Pharma, Inc. Warrants — -0.1 -4165.9 252.1 — — 2 BEARISH -83.3
RGBPP Regen BioPharma, Inc. — -0.0 20.3 12.8 -1079.8 0.0 4 BEARISH -98.9
NVAX Novavax, Inc. $1.6B -6.6 323.7 29.2 -94.2 -61.6 2 BEARISH 17.6
NUVB Nuvation Bio Inc. $1.6B -10.3 -47.8 70.2 -198.3 1083.6 4 BEARISH -6.2
MGTX MeiraGTx Holdings plc $880M 12.3 72.3 96.7 50.0 948.3 7 BEARISH 7.8
LXRX Lexicon Pharmaceuticals, Inc. $630M -9.8 -40.2 -99.7 -4591.8 -29.0 3 BEARISH 24.4
CLYM Climb Bio, Inc. $590M -11.6 -27.1 -88.6 — — 2 BEARISH 380.9
MDXG MiMedx Group, Inc. $570M 96.6 2.9 5.8 -23.1 -2.4 6 BEARISH -42.3
MNPR Monopar Therapeutics Inc. $470M -30.7 -19.5 523.8 — — 2 BEARISH -11.9
AVIR Atea Pharmaceuticals, Inc. $320M -2.0 -58.1 974.6 — — 3 BEARISH 29.9
PRQR ProQR Therapeutics N.V. $180M -3.0 -57.9 139.7 -99.6 12.7 2 BEARISH -54.0
PYXS Pyxis Oncology, Inc. $110M -1.3 -179.1 1953.9 — 291.4 2 BEARISH -46.8
INMB INmune Bio, Inc. $40M -2.2 -74.8 -475.4 — -100.0 2 BEARISH -20.0
BMEA Biomea Fusion, Inc. $40M -1.2 -164.1 210.3 — — 2 BEARISH -56.0
CELU Celularity Inc. $30M -0.4 150.9 40592.8 13.0 -58.1 4 BEARISH -61.4
TVGN Tevogen Bio Holdings Inc. $30M -1.2 235.3 244.1 — — 5 BEARISH 842.5
AVEFF Avecho Biotechnology Limited $20M -9.3 -268.2 103.4 -3227.5 -46.6 3 BEARISH 0.0
SER Serina Therapeutics, Inc. $20M -0.9 -206.3 1868.6 — -100.0 3 BEARISH -67.7
SYBX Synlogic, Inc. $10M -19.6 -5.3 306.3 — — 2 BEARISH -39.0
CMMB Chemomab Therapeutics Ltd. $10M -1.0 -82.7 -314.7 — — 1 BEARISH -68.6
XRTX XORTX Therapeutics Inc. — -0.4 -99.1 -68.5 — — 3 BEARISH 66.6
XTLB XTL Biopharmaceuticals Ltd. — -0.6 -26.8 -38.7 -88.2 — 3 BEARISH 47.1
OZYMF Strategic Partners A/S — 19.0 0.8 -117.5 1019.0 — 6 BEARISH 0.0
GNLKQ GeneLink, Inc. — -0.0 73.0 82.1 -183.0 -33.6 3 BEARISH 0.0
GLABF Gemina Laboratories Ltd. — -3.0 42.7 32.4 -7838.5 — 5 BEARISH -78.3
HXBM Helix BioMedix, Inc. — — — — — — — BEARISH -6.0
KRSA Korsana Biosciences, Inc. $150M — — — — — — BEARISH —
HBMHF HBM Holdings Limited $1.3B 12.5 24.1 53.0 53.0 54.6 4 BEARISH -38.1
GERN Geron Corporation $720M -11.5 -29.2 -74.1 -29.0 24.4 2 BEARISH -7.3
SLBT SL Science Holding Ltd $640M — — — — — — BEARISH —
GYRE Gyre Therapeutics, Inc. $620M -32.8 -15.6 -22.3 -36.4 16.8 3 BEARISH -20.1
ANNX Annexon, Inc. $610M -3.2 -105.3 -11323.3 — — 2 BEARISH 17.1
AGMB AgomAb Therapeutics N.V. American Depositary Shares $450M — — — — — — BEARISH —
ASMB Assembly Biosciences, Inc. $400M 37.0 -0.0 56.2 -28.8 125.1 4 BEARISH -30.6
RLMD Relmada Therapeutics, Inc. $350M -3.5 -55.7 460.5 — — 3 BEARISH 52.9
MPLT MapLight Therapeutics, Inc. $340M -1.6 -57.5 -366.6 — — 2 BEARISH —
CTNM Contineum Therapeutics, Inc. $270M -5.2 -28.0 -541.6 — — 4 BEARISH -18.6
LXEO Lexeo Therapeutics, Inc. Common Stock $230M -2.5 -46.8 -249.1 — — 3 BEARISH -68.9
BOVNF BioInvent International AB (publ) $220M -2.8 -88.2 20101.5 -964.0 -87.2 1 BEARISH 0.0
BBOT BridgeBio Oncology Therapeutics Inc. $210M -0.0 -56.4 -157.3 — — 1 BEARISH -75.5
MENS Jyong Biotech Ltd. Ordinary Shares $130M — — — — — — BEARISH -96.9
MIST Milestone Pharmaceuticals Inc. $80M -1.0 -35522.6 587.8 -5118.8 — 5 BEARISH -64.0
NMRA Neumora Therapeutics, Inc. Common Stock $70M -0.3 -187.1 231.9 — — 2 BEARISH -79.1
HBPCF Helix BioPharma Corp. $60M -23.6 -50.8 -21.5 — — 3 BEARISH -55.5
IMA ImageneBio Inc $50M -0.8 -40.7 -594.7 — — 3 BEARISH -49.8
PRRUF Immutep Limited $20M -0.4 -77.3 1092.5 -328.8 255.0 3 BEARISH -89.5
CLRB Cellectar Biosciences, Inc. $10M -0.3 -119.6 717.6 — — 3 BEARISH -69.8
ARNI Arno Therapeutics, Inc. — -0.0 250.7 111.6 — — 3 BEARISH 0.0
BIOAF Bioasis Technologies Inc. — -0.1 135.1 538.8 -661.8 614.1 2 BEARISH -50.0
ENLV Enlivex Therapeutics Ltd. — 0.0 209.7 -0.4 — — 5 BEARISH -99.0
MYNDF MYND Life Sciences Inc. — -2.2 9.5 34.0 — — 5 BEARISH -41.3
SEPSF Asep Medical Holdings Inc — -0.3 -36.4 -75.5 -844.8 208.8 5 BEARISH -97.2
ARUXF Acrux Limited — -7.1 -48.5 -74.2 -26.5 289.9 7 BEARISH -99.0
ZVRA Zevra Therapeutics, Inc. $580M 10.5 34.8 -1356.4 22.1 119.4 6 BEARISH -5.2
IRD Opus Genetics, Inc. $290M -2.7 -4796.5 59.8 -1072.6 -36.1 3 BEARISH 73.9
CUE Cue Biopharma, Inc. $140M -0.7 -1603.5 1241.9 -1943.2 354.4 3 BEARISH -22.2
MGNX MacroGenics, Inc. $140M -10.8 -32.6 33.8 59.4 2.3 2 BEARISH 32.6
ACRV Acrivon Therapeutics, Inc. Common Stock $70M -0.9 -64.6 5251.5 — — 1 BEARISH -15.9
SKYE Skye Bioscience, Inc. $10M -0.1 -233.9 389.5 — — 3 BEARISH -5.8
PTIX Protagenic Therapeutics, Inc. — 0.2 -485.4 -367.8 — 100.0 6 BEARISH -78.7
EMMA Emmaus Life Sciences, Inc. — -0.4 9.9 -9.3 21.2 11.0 4 BEARISH 292.2
PHRRF PharmaTher Holdings Ltd. — -7.6 -76.9 234.4 — — 2 BEARISH -56.0
RVLPQ RVL Pharmaceuticals plc — -0.0 -182.4 -101.1 -289.3 5.6 3 BEARISH 0.0
URGN UroGen Pharma Ltd. $1.7B -17.2 86.5 119.0 -19.8 169.5 2 BEARISH 78.8
MDCLF MedinCell S.A. $1.1B -29.2 472.2 81.6 -152.1 -14.8 3 BEARISH 333.5
IMMX Immix Biopharma, Inc. $680M -9.3 -34.2 1509.2 — — 4 BEARISH 123.0
CADL Candel Therapeutics, Inc. $610M -5.9 -81.8 219.4 — — 2 BEARISH 52.8
GNFTF Genfit S.A. $470M -5.2 -5084.0 -322.7 -124.0 27.5 3 BEARISH 153.5
IKT Inhibikase Therapeutics, Inc. $220M -3.3 -52.0 920.5 — — 3 BEARISH 1.9
TRGNF Transgene S.A. $120M -4.1 -64.1 -184.9 -5760.7 -185.8 4 BEARISH -53.1
PRNAF Alterity Therapeutics Limited $50M -2.2 -55.0 -401.1 — -100.0 2 BEARISH 8233.3
BOLD Boundless Bio, Inc. $50M -0.8 -67.9 807.9 — — 2 BEARISH 65.1
BMNDF Biomind Labs Inc. $20M -13.3 85.8 101.7 — — 2 BEARISH 1483.5
PBM Psyence Biomedical Ltd. — — — — — — — BEARISH -9.9
GENSF Genus plc $1.8B 5.4 45.4 9.0 80.4 -3.8 5 BEARISH -19.4
OCUL Ocular Therapeutix, Inc. $1.4B -4.7 -73.0 -31671.3 -584.5 -8.1 3 BEARISH -41.5
GPCR Structure Therapeutics Inc. $1.2B -7.1 -20.2 -1134.3 — — 3 BEARISH -18.3
SNDX Syndax Pharmaceuticals, Inc. $1.2B -5.4 -255.9 -270.9 -67.8 222.3 4 BEARISH 1.2
AKTS Aktis Oncology, Inc. $850M -15.8 -29.9 276.4 -713.5 -36.1 5 BEARISH 373763.6
ARDX Ardelyx, Inc. $770M -13.2 -38.6 -22.7 -13.8 16.8 4 BEARISH -40.5
CTMX CytomX Therapeutics, Inc. $510M -5.2 -37.8 305.9 -1457.4 -87.0 2 BEARISH -29.1
PROK ProKidney Corp. $470M -2.7 9.2 13.2 -18948.0 55.2 1 BEARISH -52.5
FTH Faeth Therapeutics, Inc. $440M — — — — — — BEARISH —
ALLO Allogene Therapeutics, Inc. $430M -1.9 -42.4 -81.9 -919.8 — 5 BEARISH 2.5
AVCTF Avacta Group Plc $420M -6.7 -2083.2 -753.6 -33970.3 -99.7 5 BEARISH -18.7
SPRY ARS Pharmaceuticals, Inc. $400M -1.7 -210.3 -424.3 -185.2 4.1 2 BEARISH -59.1
CAPR Capricor Therapeutics, Inc. $340M -2.5 -73.7 -107.5 — -100.0 3 BEARISH -1.6
KYTX Kyverna Therapeutics, Inc. $330M -1.9 -87.2 14267.8 — — 2 BEARISH -24.3
SPHDF Santhera Pharmaceuticals Holding AG $280M -6.6 729.6 111.3 -44.5 106.3 7 BEARISH 49.1
ORYZF Oryzon Genomics S.A. $250M -80.4 -3.0 -7.2 -1.6 12.6 4 BEARISH -14.1
OCGN Ocugen, Inc. $250M -2.9 1211.7 190.2 -1671.8 -3.7 2 BEARISH -52.4
ABEO Abeona Therapeutics Inc. $250M -3.9 -43.1 -5983.3 -177.4 6280.0 2 BEARISH -18.8
VNDA Vanda Pharmaceuticals Inc. $240M -0.9 -77.8 -201.0 -123.7 6.0 3 BEARISH -27.4
HLOSF Healios K.K. $240M 56.3 3.7 -129.2 17028.6 -47.1 4 BEARISH -48.6
IPHYF Innate Pharma S.A. $210M -2.5 267.9 119.2 -343.8 32.0 3 BEARISH -24.5
BIOA BioAge Labs Inc. $190M -2.3 -28.2 -142.3 -1064.7 168.1 4 BEARISH -28.0
EVMN Evommune, Inc. $190M -1.5 -29.6 -82.4 — — 2 BEARISH —
NBP NovaBridge Biosciences $160M -2.2 -45.7 -617.8 — — 1 BEARISH -70.4
SION Sionna Therapeutics, Inc. $160M -1.8 -32.3 -137.7 — — 0 BEARISH -90.1
AKBA Akebia Therapeutics, Inc. $160M -6.1 -109.4 15.6 -18.1 7.5 6 BEARISH -78.2
ZNTL Zentalis Pharmaceuticals, Inc. $160M -0.8 -83.7 -2245.4 — -100.0 2 BEARISH 15.8
NGEN NervGen Pharma Corp. Common stock $150M — — — — — — BEARISH —
CNTN Canton Strategic Holdings Inc $150M -1.2 -14.6 -7.2 -1287.2 — 2 BEARISH —
STRO Sutro Biopharma, Inc. $150M -0.5 266.8 43.6 -391.6 -56.3 4 BEARISH -15.5
CDXS Codexis, Inc. $140M -3.8 -69.4 -37.8 -80.5 35.9 3 BEARISH -52.6
NKTX Nkarta, Inc. $130M -1.1 -38.8 -75.4 — — 1 BEARISH -15.0
AVXL Anavex Life Sciences Corp. $120M -4.9 -23.6 411.7 — — 2 BEARISH -84.8
CBUS Cibus, Inc. $110M -0.8 -225.9 -157.2 -2227.9 -10.3 2 BEARISH -11.0
VXRT Vaxart, Inc. $100M 2.7 67.0 149.6 -49.6 201.1 6 BEARISH 10.8
CLLS Cellectis S.A. $100M -1.7 -94.6 118.6 -417.3 0.5 2 BEARISH -69.8
ORPOF OSE Immunotherapeutics S.A. $100M — — — — — — BEARISH —
TNYA Tenaya Therapeutics, Inc. $90M -0.7 -121.9 1769.3 -3909.3 — 3 BEARISH -75.8
CRBP Corbus Pharmaceuticals Holdings, Inc. $80M -0.6 -95.6 738.2 — — 1 BEARISH -75.4
JWCTF JW (Cayman) Therapeutics Co. Ltd $80M -2.3 -49.0 -68.1 -45.3 60.7 3 BEARISH -55.3
CRDF Cardiff Oncology, Inc. $70M -1.5 -94.1 443.4 -8876.9 -7.0 3 BEARISH -60.8
CGTX Cognition Therapeutics, Inc. $70M -3.9 -83.8 6061.8 — — 3 BEARISH -56.1
CRBU Caribou Biosciences, Inc. $60M -0.4 -78.3 -695.0 -1619.9 10.0 3 BEARISH -81.5
IBIO iBio, Inc. $50M -2.3 -65.7 21688.6 — -75.0 4 BEARISH -36.6
HYFT MindWalk Holdings Corp. $50M -4.4 -123.5 -481.3 -158.7 -15.9 4 BEARISH -29.3
VTIAF FamiCord AG $50M -6.4 -84.3 -13.6 -5.1 0.1 5 BEARISH -55.7
CNTB Connect Biopharma Holdings Limited $50M -0.9 -105.5 1034.1 -1249.0 49.8 2 BEARISH -50.4
EXOZ eXoZymes, Inc. $40M -3.3 -187.2 913.0 — — 2 BEARISH -68.4
TIL Instil Bio, Inc. $40M -1.3 -25.3 -69.1 — — 4 BEARISH -69.9
ALDX Aldeyra The $40M -1.6 -49.5 269.3 — — 4 BEARISH -87.8
ANVS Annovis Bio, Inc. $40M -0.6 -703.7 170.2 — — 1 BEARISH -49.8
DWTX Dogwood Therapeutics, Inc. $40M -0.1 -47.8 -39.7 — — 2 BEARISH -80.3
RANI Rani Therapeutics Holdings, Inc. $40M -2.2 -179.1 245.5 -432.7 306.4 5 BEARISH -66.5
IGC IGC Pharma, Inc. $30M -3.0 -129.2 -127.6 -1107.9 -15.4 1 BEARISH -39.1
IXHL Incannex Healthcare Limited $30M -2.4 -31.9 5284.2 — -100.0 4 BEARISH -75.0
GRCE Grace Therapeutics, Inc. $30M -1.4 -38.4 -58.9 — — 2 BEARISH -40.5
FLNA Filana Therapeutics, Inc. $30M -0.7 -13.5 38.9 — — 2 BEARISH —
BCTX BriaCell Therapeutics Corp. $30M -0.3 -179.9 -2435.2 — — 2 BEARISH -74.2
MVMDF More Life Company Corp. $20M -5.2 -167.0 -602.2 -5006.5 43.0 4 BEARISH 115.8
BYSI BeyondSpring Inc. $20M -2.9 20.3 15.7 — 100.0 2 BEARISH -77.0
ATYR aTyr Pharma, Inc. $20M -0.2 -98.4 -1890.1 — — 2 BEARISH -87.4
BLRX BioLineRx Ltd. $10M -1.1 -63.5 -113.0 -1029.3 -94.3 3 BEARISH -44.6
INAB IN8bio, Inc. $10M -0.5 -111.1 -576.1 — — 4 BEARISH -55.1
QNRX Quoin Pharmaceuticals, Ltd. $10M -0.3 -578.6 221.3 — — 1 BEARISH -68.7
RDTCF Rapid Dose Therapeutics Corp. $10M -4.2 49.3 80.2 -86.2 4.3 4 BEARISH -58.4
OPTBF OptiBiotix Health Plc $10M -1.4 -102.1 -102.1 -231.5 -12.9 4 BEARISH 109900.0
MSLE Satellos Bioscience Inc. $10M — — — — — — BEARISH —
VTGN VistaGen Therapeutics, Inc. $10M -0.1 -166.5 851.1 -882.8 287.3 4 BEARISH -95.7
TPST Tempest Therapeutics, Inc. $10M -0.1 -931.1 -564.2 — — 1 BEARISH -95.2
CDIO Cardio Diagnostics Holdings, Inc. $10M -0.6 -75.4 -230.9 -28012.5 -25.9 3 BEARISH -58.0
TRAW Traws Pharma, Inc. $10M -0.7 -711.4 133.9 — -100.0 1 BEARISH -87.4
APRE Aprea Therapeutics, Inc. $10M -0.5 -47.4 378.1 — -99.8 2 BEARISH -62.7
PTN Palatin Technologies, Inc. $10M -0.9 -877.5 1176.9 -1449.1 — 5 BEARISH -20.5
GUTS Fractyl Health, Inc. $10M -0.1 1063.0 -568.7 — -100.0 5 BEARISH -94.7
TOVX Theriva Biologics, Inc. $10M -0.3 -101.9 -213.5 — — 2 BEARISH -45.5
TCRX TScan Therapeutics, Inc. $10M -0.2 -95.8 -159.4 -2888.6 2.2 2 BEARISH -91.7
TVRD Tvardi Therapeutics, Inc. $10M -0.3 -126.2 296.9 — — 1 BEARISH -82.6
KTTA Pasithea Therapeutics Corp. $10M -0.2 -65.5 -453.2 — — 4 BEARISH -44.7
GTBP GT Biopharma, Inc. $10M -0.1 -798.9 927.8 — — 2 BEARISH -67.4
PXXLF Poxel S.A. $10M -0.4 34.8 129.6 -624.6 41.5 4 BEARISH -12.0
DARE Dare Bioscience, Inc. $10M -0.8 165.3 136.8 -1590.4 7816.7 3 BEARISH -68.6
GSGTF GenSight Biologics S.A. $10M -1.0 46.5 47.3 1190.6 -401.7 3 BEARISH -57.9
QNTM Quantum BioPharma Ltd. $10M -0.4 -425.3 175.1 — — 4 BEARISH -83.3
INTS Intensity Therapeutics, Inc. $10M -0.7 -195.9 4123.4 — — 5 BEARISH -46.4
IMNN Imunon, Inc. $10M -0.2 -429.7 -226.7 — — 2 BEARISH -81.9
SUVZ Suvanza Pharma, LLC — — — — — — — BEARISH 0.0
HCWB HCW Biologics Inc. — -0.0 -133.5 -36.8 -3849.9 707.0 3 BEARISH -95.2
LIFS Life Stem Genetics Inc. — -2.5 -126.7 -111.5 — — 2 BEARISH -50.0
RADX Radiopharm Theranostics Limited — — — — — — — BEARISH -83.1
MBAI MBody AI Ltd. — — — — — — — BEARISH —
APVO Aptevo Therapeutics Inc. — -0.0 -420.3 -4688.7 — — 1 BEARISH -95.2
KAPA Kairos Pharma, Ltd. — -0.3 -114.0 -301.0 — — 3 BEARISH -93.0
DCOY Decoy Therapeutics Inc. — — — — — — — BEARISH —
ENZC Enzolytics Inc. — -11.2 105.9 1.4 — — 7 BEARISH -25.0
RASP Actavia Life Sciences, Inc. — -0.1 20.1 14.5 — — 2 BEARISH -87.5
EVFM Evofem Biosciences, Inc. — -0.1 20.1 26.0 -419.1 4.5 2 BEARISH -27.3
CLDI Calidi Biotherapeutics, Inc. — -0.0 -713.6 -1404.6 — — 4 BEARISH -97.3
MBIO Mustang Bio, Inc. — -0.8 -58.1 36.6 — — 2 BEARISH -75.9
LIMN Liminatus Pharma, Inc. Class A Common Stock — -0.1 294.4 252.1 — — 4 BEARISH -95.3
KALA KALA BIO, Inc. — -0.0 -345.3 -913.5 — -100.0 4 BEARISH -99.6
TSOI Therapeutic Solutions International, Inc. — -0.1 -187.6 -130.3 -5123.0 -99.7 4 BEARISH -99.0
WSNAF Wesana Health Holdings Inc. — -0.1 1113.6 90.8 — — 3 BEARISH -80.1
GNPX Genprex, Inc. — -0.0 -203.9 3484.8 — — 4 BEARISH -99.1
NCEL NewcelX Ltd. — 8.0 -48.0 -39.1 — — 2 BEARISH -79.5
OGEN Oragenics, Inc. — -0.1 -1307.1 4273.7 — — 3 BEARISH -72.3
NBRVF Nabriva Therapeutics plc — — — — — — — BEARISH 0.0
BNIGF Beroni Group Limited — -0.1 -1153.4 -274.8 -15945.7 40.9 5 BEARISH 0.0
ZVSA ZyVersa Therapeutics, Inc. — -0.0 817.1 242.0 — -100.0 1 BEARISH -99.3
NIKI Niki BioSolutions, Inc. — — — — — — — BEARISH —
GOVX GeoVax Labs, Inc. — -0.0 -891.6 1530.7 — -100.0 3 BEARISH -98.6
VBIO Valion Bio, Inc. — -0.0 -240.8 -48.0 — -281.4 2 BEARISH —
AXIM AXIM Biotechnologies, Inc. — -1.6 3.0 24.9 -90.9 2142.6 5 BEARISH -62.2
TNGNQ Tengion, Inc. — — — — — — — BEARISH 0.0
XENO Xeno Transplants Corporation — -0.0 -286.5 78.1 — — 1 BEARISH 0.0
ZHCLF Zenith Capital Corp. — -0.2 35107.2 37766.2 -360.0 — 3 BEARISH 3233.3
MLECW Moolec Science S.A. — -0.0 -174.7 -31.5 -91.8 170.4 3 BEARISH -38.8
MDCX Medicus Pharma Ltd. Common Stock — -0.0 -3904.0 -693.1 — — 3 BEARISH -98.2
VPRO Viropro Inc. — -0.0 -19.7 -4.8 -269.7 155.0 2 BEARISH 0.0
IVEVF Inventiva S.A. $750M -6.2 -988.4 -371.6 -347346.6 -99.7 3 BEARISH -22.8
RGNX REGENXBIO Inc. $440M -1.7 -137.6 -368.4 21.0 12.0 2 BEARISH -49.4
ALT Altimmune, Inc. $410M -2.6 -28.9 -43.1 — 55.0 4 BEARISH -46.0
AVTX Avalo Therapeutics, Inc. $370M -1.4 -36.3 -148.4 — -86.6 4 BEARISH -61.6
DMTRF 3-D Matrix, Ltd. $310M 11.9 75.0 31.1 9.4 57.0 6 BEARISH 61.3
CABA Cabaletta Bio, Inc. $250M -0.9 -93.2 -1308.0 — — 3 BEARISH -40.9
ACIU AC Immune S.A. $250M -4.2 -78.5 96.7 12.4 -39.5 2 BEARISH -30.8
SCTX Scribe Therapeutics Inc. $250M — — — — — — BEARISH —
PALI Palisade Bio, Inc. $230M -2.3 -51.4 815.6 -2114.8 — 5 BEARISH -31.0
IVVD Invivyd, Inc. $180M -1.5 -95.9 -302.5 -310.8 26.3 2 BEARISH -73.2
UPB Upstream Bio, Inc. $150M -1.0 -46.0 -1266.4 -5136.1 49.2 3 BEARISH -83.0
CMPX Compass Therapeutics, Inc. $140M -1.8 -56.7 1526.3 — — 4 BEARISH -81.2
VYGR Voyager Therapeutics, Inc. $110M -1.0 -54.1 -131.1 -773.2 -19.1 2 BEARISH -62.8
NERV Minerva Neurosciences, Inc. $110M -0.1 337.5 10.0 — — 1 BEARISH -52.5
VTVT vTv Therapeutics Inc. $100M -236.4 -11.7 91.2 — 216600.0 4 BEARISH 23.1
LENZ LENZ Therapeutics, Inc. $100M -0.8 -59.2 17313.3 -581.8 329.5 3 BEARISH -90.2
ENGN enGene Holdings Inc. $100M -5.6 -2.3 134.1 — -100.0 2 BEARISH -81.3
PTHS Pelthos Therapeutics Inc. $70M -0.3 4767.3 -97.0 -150.1 — 2 BEARISH -54.0
TLSA Tiziana Life Sciences Ltd $60M -4.3 -780.6 375.0 — — 1 BEARISH -55.0
VRCA Verrica Pharmaceuticals Inc. $60M -2.0 473.3 437.4 -224.4 106.2 5 BEARISH -9.9
XBIT XBiotech Inc. $60M -1.3 -29.9 -201.2 — — 2 BEARISH -28.0
GANX Gain Therapeutics, Inc. $50M -2.4 -268.3 1288.8 — — 4 BEARISH -40.9
PLRX Pliant Therapeutics, Inc. $50M -0.6 -50.3 -438.3 — — 3 BEARISH -53.6
KLRS Kalaris Therapeutics Inc $40M -0.9 -79.9 109.5 — — 0 BEARISH -61.0
ACET Adicet Bio, Inc. $40M -0.3 -78.1 -553.5 — — 4 BEARISH -73.2
NRXBF NurExone Biologic Inc. $30M — — — — — — BEARISH —
EYPT EyePoint Pharmaceuticals, Inc. $30M -0.1 -148.7 -3014.8 -18633.1 -94.6 2 BEARISH -97.0
ALGS Aligos Therapeutics, Inc. $30M -0.7 -113.6 -1246.4 -5.4 893.0 2 BEARISH -51.1
EDSA Edesa Biotech, Inc. $30M -1.6 -122.9 759.6 — — 1 BEARISH -2.5
AARD Aardvark Therapeutics, Inc. Common Stock $30M -0.4 -66.0 -3642.4 — — 1 BEARISH -87.8
MGX Metagenomi, Inc. Common Stock $30M -0.3 -60.6 -268.2 10693.4 -59.8 1 BEARISH -72.3
BSEM BioStem Technologies, Inc. $30M -0.9 -74.7 -84.3 -113.6 -119.6 2 BEARISH -69.0
TELIF Telescope Innovations Corp. $20M 6.0 -229.2 -80.7 -116.8 66.3 2 BEARISH -21.7
MCRB Seres Therapeutics, Inc. $20M -0.8 -66.6 -87.8 622.4 — 3 BEARISH -89.9
KYNB Kyntra Bio, Inc. $20M 0.1 -115.2 29.6 -812.3 — 2 BEARISH —
BXPHF Botanix Pharmaceuticals Limited $20M -0.3 -96.3 -131.6 -203.1 495.6 4 BEARISH -91.5
ACTU Actuate Therapeutics Inc $10M -0.4 2457.6 541.3 — — 3 BEARISH -94.5
FBLG FibroBiologics, Inc. Common Stock $10M -0.2 -660.1 -511.6 — — 4 BEARISH -89.3
AIMD Ainos, Inc. $10M -0.3 -196.3 -69.4 -3022849.3 -87.7 1 BEARISH -77.5
ACXP Acurx Pharmaceuticals, Inc. $10M -0.3 -128.1 241.9 — — 3 BEARISH -83.7
BCDA BioCardia, Inc. $10M -1.2 -1803.2 519.4 — — 3 BEARISH -33.7
HIND Vyome Holdings, Inc. $10M -0.1 -193.1 516.3 -2543.3 -98.0 4 BEARISH -69.0
MTVA MetaVia Inc. $10M -0.3 -175.7 209.3 — — 0 BEARISH -89.3
RVPH Reviva Pharmaceuticals Holdings, Inc. $10M -0.1 -32.2 45.6 — — 4 BEARISH -33.4
CODX Co-Diagnostics, Inc. — -0.0 -174.8 -218.8 -3782.4 -28.1 3 BEARISH -95.5
NAVBQ Navidea Biopharmaceuticals, Inc. — — — — — — — BEARISH —
LABT Lakewood-Amedex Biotherapeutics, Inc. — — — — — — — BEARISH —
FAMDF Futura Medical plc — -0.3 -145.8 -370.5 -72.8 -70.7 2 BEARISH -86.7
NSHSF NanoSphere Health Sciences Inc. — 9.5 4.6 11.1 — — 0 BEARISH 0.0
CANF Can-Fite BioPharma Ltd. — -0.3 -184.2 353.7 -2277.7 -40.1 2 BEARISH -81.7
PPBT Purple Biotech Ltd. — -0.0 -111.3 -99.1 — — 2 BEARISH 56.6
NRSN NeuroSense Therapeutics Ltd. — -0.3 779.3 571.3 — — 3 BEARISH -90.0
NMLSF Restart Life Sciences Corp. — -1.8 -214.3 -153.9 -307.0 — 2 BEARISH -63.3
ZLDAF Zelira Therapeutics Limited — -1.6 80.8 147.8 -185107971.7 -99.3 1 BEARISH -7.8
PMCB PharmaCyte Biotech, Inc. — -0.1 -44.0 793.8 — — 2 BEARISH -64.9
SCPX Scorpius Holdings, Inc. — -0.0 0.0 0.0 -428.3 -75.5 0 BEARISH -66.7
CELZ Creative Medical Technology Holdings, Inc. — -0.3 -78.0 8335.2 — -50.0 2 BEARISH -85.9
CRIS Curis, Inc. — -0.0 455.3 -23281.0 — -62.2 3 BEARISH -98.8
OXBOF Oxford BioDynamics Plc — -0.3 -214.9 -155.8 -649.8 33.6 3 BEARISH -81.1
XSNX NovAccess Global Inc. — -0.0 27.7 18.0 — — 3 BEARISH 0.0

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

UNCY vs Benchmarks

ROIC
UNCY
349.9
Industry
10.0
P/E Ratio
UNCY
-2.1
Sector
17.0
ROE
UNCY
-101.1
Sector
-70.3
Piotroski F
UNCY
4.0
Sector
3.0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms